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 ABSTRACT 
 
 
Effectiveness of Acceptance and Commitment Therapy as a Treatment for  
 
Posttraumatic Stress Disorder and Moral Injury  
 
 
by  
 
 
Ellen J. Bluett, Doctor of Philosophy  
 
Utah State University, 2017 
 
 
Major Professor: Michael P. Twohig, Ph.D. 
Department: Psychology  
 
 
Posttraumatic stress disorder (PTSD) is a common condition among military 
personal and veterans. Despite strong empirical support for first line treatments for 
PTSD, many veterans do not complete or respond to treatment. Research suggests that 
experiential avoidance is a contributing factor to both treatment dropout and minimal 
treatment gains. Acceptance and commitment therapy (ACT) is an empirically supported 
cognitive behavioral intervention that aims to decrease experiential avoidance while 
increasing psychological flexibility. Research has shown ACT to be a promising 
intervention for the treatment of PTSD; however, its effectiveness in veterans with PTSD 
is limited. Implementing an 8-week closed group design, this study examined the 
effectiveness of an ACT intervention for veterans with PTSD and subclinical PTSD who 
had previously completed a first line intervention for PTSD. Thirty-three veterans 
enrolled in the intervention, which focused on vitality (e.g., increasing valued living and 
iv 
 
decreasing experiential avoidance) rather than symptom reduction. Symptom and process 
of change measures including PTSD symptoms, valued living, and quality of life were 
measured at pretreatment, posttreatment, and again at 1-month follow-up. Results found 
that 64.7% of veterans showed a favorable response to treatment as measured by a 5-
point change in PTSD symptoms. Additionally, outcomes of interest including PTSD 
symptoms, valued living, depression, wellbeing, and moral injury by transgressions 
improved from pretreatment to posttreatment. Of note, a majority of treatment gains were 
not maintained at follow-up. Overall, results provide preliminary support for ACT as a 
second-line intervention for veteran PTSD. Empirical and clinical implications are 
discussed along with the potential limitations and future directions of this study.  
(161 pages) 
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PUBLIC ABSTRACT  
 
 
Effectiveness of Acceptance and Commitment Therapy as a Treatment for  
 
Posttraumatic Stress Disorder and Moral Injury  
 
 
Ellen J. Bluett 
 
Posttraumatic stress disorder (PTSD) is a common condition among military 
personal and veterans. Despite strong empirical support for first line treatments for 
PTSD, many veterans do not complete or respond to treatment. Research suggests that 
experiential avoidance is a contributing factor to both treatment dropout and minimal 
treatment gains. Acceptance and commitment therapy (ACT) is an empirically supported 
cognitive behavioral intervention that aims to decrease experiential avoidance while 
increasing psychological flexibility. Research has shown ACT to be a promising 
intervention for the treatment of PTSD; however, its effectiveness in veterans with PTSD 
is limited.  
In conjunction with Utah State University (USU) and the Salt Lake City Veterans 
Affairs Medical Center, Ellen Bluett, a USU doctoral psychology student and staff 
psychologist at the VA conducted a study to examine a next-step treatment for veterans 
with PTSD. The main purpose of this study was to examine the effectiveness of an 8-
week closed group design ACT intervention for veterans with PTSD and subclinical 
PTSD who had previously completed a first line intervention for PTSD. Thirty-three 
veterans enrolled in the intervention, which focused on vitality (e.g., increasing valued 
living and decreasing experiential avoidance) rather than symptom reduction. Symptom 
vi 
 
and process of change measures including PTSD symptoms, valued living, and quality of 
life were measured at pretreatment, posttreatment, and again at 1-month follow-up. 
Findings from this study showed that 64.7% of veterans showed a favorable 
response to treatment as measured by a 5-point change in PTSD symptoms. Additionally, 
outcomes of interest including PTSD symptoms, valued living, depression, wellbeing, 
and moral injury by transgressions improved from pretreatment to posttreatment. Of note, 
a majority of treatment gains were not maintained at follow-up. Overall, results provide 
preliminary support for ACT as a second-line intervention for veteran PTSD.  
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CHAPTER I 
 
INTRODUCTION 
 
 
Posttraumatic Stress Disorder (PTSD) is classified as a trauma and stressor related 
disorder that is associated with severe stress reactions from exposure to a traumatic event 
(American Psychiatric Association [APA], 2013). An estimated 50% of women and 60% 
of men in the U.S. are exposed to a traumatic event during their lifetimes (Kessler, 
Sonnega, Bromet, Hughes, & Nelson, 1995). Lifetime prevalence for PTSD rates range 
from 7.8 to 25% (Green & Kaltman, 2003; Hidalgo & Davidson, 2000; Kessler et al., 
1995). According to Gates and colleagues the occurrence of PTSD is higher amongst 
active military personal and veterans than the civilian population (Gates et al., 2012). 
Furthermore, PTSD has been identified as a “signature injury” amongst service members 
returning from deployments to Afghanistan to serve in OEF (Operation Enduring 
Freedom) and deployments to Iraq to serve in OIF (Operation Iraqi Freedom; Gates et al., 
2012).  
Military related trauma has other notable effects, including the potential to 
damage or transgress an individual’s moral or ethical codes. Therefore, unsurprisingly 
exposure to war can be instrumental in the development of moral injury (Farnsworth, 
Drescher, Nieuwsma, Walser & Currier, 2014; Litz et al., 2009). Morally injurious 
experiences include “perpetrating, failing to prevent, bearing witness to, or learning about 
acts that transgress deeply held moral beliefs and expectations” (Litz et al., 2009, p. 697). 
While, the etiology of moral injury shares similarities to fear conditioning and cognitive 
models of PTSD, they are not one and the same (Nash & Litz, 2013). There is a growing 
body of research aiming to understand how moral injury relates to posttraumatic stress 
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(Farnsworth et al., 2014). Furthermore, no evidence-based treatments have been 
developed for moral injury.  
Importantly, while effective treatments exist for PTSD- such as prolonged 
exposure and cognitive processing therapy, they are not without limitations. In fact, many 
individuals do not respond, demonstrate minimal gains posttreatment, and do not 
complete treatment (Garcia, Kelley, Rentz, & Lee, 2011; Steenkamp, Litz, Hoge, & 
Marmar, 2015). Furthermore, dropout rates among the gold-standard treatments range 
between 0 and 54% (Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008). Some 
literature suggests that avoidance may be the underlying factor contributing to treatment 
dropout and poor treatment gains (Walser & Westrup, 2007). Recently, there has been 
considerable research examining the role of experiential avoidance in the development 
and maintenance of PTSD (Walser & Westrup, 2007). Experiential avoidance is a method 
of actively avoiding or escaping particular private experiences, which is inversely related 
to overall psychological functioning. Additionally, higher rates of experiential avoidance 
correlate with poorer psychological functioning (e.g., Hayes, 2004; Walser & Westrup, 
2007). Furthermore, experiential avoidance often reduces an individual’s ability to 
engage in meaningful, values driven behaviors. In sum, research on alternative or 
secondary treatment options for PTSD- that target experiential avoidance is warranted.  
Acceptance-based interventions target experiential avoidance and promote 
willingness to experience thoughts, feelings, and/or emotions, without changing their 
form, meaning, or frequency. Ultimately, acceptance allows an individual to engage in 
life regardless of the severity of their internal experiences. One such therapy, acceptance 
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and commitment therapy (ACT) has growing support as an intervention for anxiety 
disorders (Arch et al., 2012; Bluett, Homan, Morrison, Levin, & Twohig, 2014; Ruiz, 
2010). The primary focus of an ACT treatment model is to increase behaviors that are 
consistent with personal values while simultaneously allowing for any given internal 
experience to be present. The emphasis on treatment is to increase vitality, rather than to 
reduce symptoms. Furthermore, several small studies have provided preliminary support 
for the use of ACT for PTSD.  
  Taken together, the prevalence and chronicity of PTSD and moral injury amongst 
military personal, along with the limitations of existing treatments, warrants the 
investigation of alternative treatment options for veterans with PTSD. Given the marked 
avoidance and broken or betrayed sense of self often experienced by veterans with PTSD, 
suggests that ACT may be useful at treating trauma associated with moral injury events. 
Additionally, empirical support exists for group-based interventions for PTSD (Sloan, 
Feinstein, Gallagher, Beck, & Keane, 2013). The purpose of this study is to examine the 
effectiveness of an ACT group intervention for PTSD in veterans.  
This study sought to answer the following research questions. 
1. Is ACT an effective treatment for veterans with PTSD? Specifically, does 
ACT positively impact PTSD symptom severity, quality of life, valued living, 
depression, shame, and moral injury? 
2. Do pretreatment levels of depression, moral injury, shame, psychological 
inflexibility, and cognitive fusion predict response to treatment?  
3. Do changes in psychological flexibility (AAQ-II) and valued living (VQ) 
predict PTSD symptom severity posttreatment? 
4. Is a group-based ACT intervention an acceptable treatment for veterans 
diagnosed with PTSD? 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
 
Posttraumatic Stress Disorder 
 
 
PTSD is classified as a trauma and stressor related disorder that is associated with 
severe stress reactions from exposure to a traumatic event. According to the DSM-5 
(APA, 2013) a criterion “A” traumatic event is characterized as an event that threatens or 
causes death, serious injury, or sexual violence to self or others. Traumatic events include 
but are not limited to combat, natural disasters, motor-vehicle accidents, sexual assaults, 
physical assaults, and sudden death of a loved one. Of note, the DSM-5 states that one or 
more traumatic events (e.g., combat exposure) may be included in the diagnosis of PTSD 
(APA, 2013). Four symptoms clusters characterize PTSD: re-experiencing or intrusion 
(e.g., trauma related memories, flashbacks), avoidance of trauma-related internal or 
external stimuli, alterations in arousal and reactivity (e.g., sleep disturbance, easily 
startled), and negative changes in mood and cognitions following the traumatic event 
(APA, 2013). In order to meet criteria for PTSD, symptoms must persist for at least a 
month after the traumatic event, create significant dysfunction, and cannot be attributable 
to substance use or another medical condition. 
 
Prevalence 
 
An estimated 50% of women and 60% of men in the U.S. are exposed to a 
traumatic event during their lifetime (Kessler et al., 1995). Despite the frequency of 
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trauma exposure, only a subset of the population develops PTSD (APA, 2000). Lifetime 
prevalence rates for PTSD range from 7.8 to 25% (Green & Kaltman, 2003; Hidalgo & 
Davidson, 2000; Kessler et al., 1995). A recent study examined PTSD prevalence rates 
utilizing the DSM-5 criteria. Overall, prevalence rates for PTSD were slightly lower 
using the DSM-5 criteria compared to the DSM-IV criteria. Unique to this study, 
individuals with composite event PTSD, or PTSD symptomology attributable to a 
combination of traumatic events versus PTSD criteria attributable to a single event per se, 
were included. Of the 2,953 participating in the study, 89.7% reported experiencing one 
or more criterion “A” traumas, with the average frequency of trauma exposure being 
three events. Prevalence rates for individuals with composite event PTSD were as 
follows: 9.4% lifetime, 5.3% in the past 12 months, and 4.2% in 6 months. For 
individuals with same event PTSD, that is, all symptom criteria matching to the same 
reported traumatic event, prevalence rates were 8.3% for lifetime, 4.7% in the past 12 
months, and 3.8% in the past 6 months (Kilpatrick et al., 2013). In sum, regardless of 
DSM edition, epidemiology research suggests that the frequency of PTSD is a substantial 
and growing problem.  
According to Gates and colleagues the occurrence of PTSD is higher amongst 
active military personal and veterans than the civilian population (Gates et al., 2012) 
PTSD has been identified as a “signature injury” amongst service members returning 
from deployments to Afghanistan to serve in OEF and Iraq for OIF (Gates et al., 2012). 
PTSD prevalence rates for recently deployed U.S. military personnel are as high as 14 to 
16% (Gates et al., 2012; Tanielian & Jaycox, 2008). A report conducted by the 
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Department of Veteran Affairs in June, 2009, suggested that nearly 25% of OEF/OIF 
veterans receiving care at a VA were diagnosed with possible PTSD (Karlin et al., 2010). 
This percentage approximates to nearly 120,000 veterans, indicating the urgency and 
demand for providing evidence-based treatments for PTSD to U.S. veterans. These 
findings are supported by a recent study reporting a 13.5 % weighted prevalence rate of 
PTSD among more than 20,000 veterans serving between October 2001 and June 2008. 
In this study, prevalence rates were higher for veterans who were deployed (15.7%) than 
those who were not deployed (10.9%; Dursa, Reinhard, Barth & Schneiderman, 2014). 
Additionally, a longitudinal study found that 11% of Vietnam veterans continue to 
struggle with PTSD (Marmar, Schlenger, Henn-Hasse, 2015).  
Moreover, a large body of evidence suggests that PTSD has detrimental effects on 
the lives of active U.S. military personnel, veterans, and their families. Various negative 
outcomes include increased anger and hostility (Jakupcak et al., 2007), occupational 
insecurities and legal trouble (Solomon & Davidson, 1997), physical health problems 
(Breslau & Davis, 1992; Schnurr & Green, 2004), as well as interpersonal problems 
(Taft, Watkins, Stafford, Street, & Monson, 2011). In addition, studies have shown that 
depression and anxiety (Rauch et al., 2010) and suicidal ideation (Jakupcak et al., 2009) 
are more likely amongst veterans diagnosed with PTSD compared to veterans without 
PTSD. Furthermore, one study reported that over 400,000 veterans received 
compensation for PTSD (U.S. Department of Veterans Affairs, 2011). Overall, the 
psychosocial impact of PTSD is marked and demands further attention. Military related 
trauma has other notable effects, including moral transgression.  
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Moral Injury 
 
The construct of moral injury has recently gained attention as a psychological 
wound resulting from military service (Farnsworth et al., 2014). Moral injury has been 
defined two ways. The founder of the term, Jonathon Shay, defines moral injury as a 
psychological consequence resulting from a betrayal of what is considered right or moral 
in a “high stakes” situation by an individual in a position of authority (Shay, 2014). 
Alternatively, Litz et al. (2009) defined moral injury as a psychological state resulting 
from an event in which an act or transgression occurs that opposes an individual’s 
expectations about how one should behave (Litz et al., 2009). Both definitions include a 
violation of one’s moral or ethical codes, however, a disparity exists in who is the 
violator. Shay considers the person of power the violator while Litz et al. perceive the 
violator to be the individual or the “self” (Litz et al., 2009; Shay, 2014). A further 
distinction is that Shay purported that physiological arousal was a component of moral 
injury. Regardless of the model applied, moral injury occurs when one’s moral 
expectations are violated and/or invalidated by an event (Nash & Litz, 2013). Moral 
injury appears to be a novel construct that extends beyond the DSM-5 criteria of PTSD. 
Specifically, research suggests that moral challenges faced in a war may be an alternative 
category of traumatic events, which is not captured in the current diagnostic criteria 
(Currier et al., 2015). Moreover, the events that contribute to moral injury are customary 
to modern day war.  
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Morally Injurious Events 
War can be instrumental in the development of moral injury (Currier, 
McCormick, & Drescher, 2015; Litz et al., 2009). Morally injurious experiences include 
“perpetrating, failing to prevent, bearing witness to, or learning about acts that transgress 
deeply held moral beliefs and expectations” (Litz et al., 2009, p.700). At the root of moral 
injury is the violation of morals, “fundamental assumptions about how things should 
work and how one should behave in the world” (Litz, et al., p. 699). Litz et al. proposed 
that the nature of wars in Iraq and Afghanistan are “unconventional,” including guerilla 
warfare in an urban environment highlighted by civilian threats, IEDs (improvised 
explosive devises), unmarked enemies, as well as increased danger for civilians and non-
combat troops (Litz et al., 2009). Therefore, the unpredictable nature of modern day war 
presents veterans with an increasing number of scenarios in which they are forced to 
battle and possibly transgress their personal moral codes. Such moral conflicts include 
killing an insurgent appearing as a civilian, witnessing dead bodies, and failing to assist 
injured women and children (Litz et al., 2009). Ultimately, exposure to moral conflict 
increases the likelihood of moral violation, resulting in emotions of shame, guilt, failure 
for self-forgiveness, social problems, struggles with spirituality, and self-ridicule 
(Drescher et al., 2011). Also, trust becomes a fundamental problem for individuals 
inflicted with moral injury (Shay, 2014). Importantly, these peritraumatic and 
posttraumatic emotions have been associated with both combat related moral injury and 
military related PTSD (Farnsworth et al.,).  
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Distinction from PTSD 
PTSD is considered one of the “diagnostic correlates” of moral injury 
(Farnsworth et al., 2014, p. 256). However, moral injury is not covered within the DSM-5 
diagnostic criteria. To date, the literature distinguishes moral injury from PTSD in that 
the event related to moral injury does not need to be perceived as life threatening. A 
recent qualitative study aimed to evaluate and further define the construct of moral injury 
outside of PTSD. In this study, 23 mental-health workers, chaplains, and researchers were 
interviewed on their perception of an initial definition of moral injury and related 
components. Overall, results showed that participants agreed that specific morally 
injurious events occur that result in many psychological, spiritual, and behavioral 
problems. Unanimously, the interviewees agreed that the construct of moral injury is both 
necessary and affiliated with the diagnosis of PTSD but is not fully captured in the 
diagnostic criteria (Drescher et al., 2011). In conclusion, this study indicated the 
importance of moral injury as a construct and suggested that further measures of moral 
injury be developed.  
The growing literature on moral injury suggests that there are similarities in the 
development of PTSD and moral injury (Farnsworth et al., 2014). Although moral injury 
may be a distinct construct, various models of PTSD may contribute to the understanding 
of moral injury. For example, social cognitive theories of PTSD purport that one’s basic 
assumptions and beliefs about the world and self are violated as a result of a traumatic 
experience. Within this model, failure to reconcile the event within one’s personal beliefs 
may create guilt, shame, and distorted views of the self and world, all of which are 
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associated with moral injury (Litz et al., 2009). Moreover, a qualitative analysis of 14 
veterans from Iraq and Afghanistan, examined why moral injury may have occurred 
during deployment. Veterans in the study were more likely to attribute psychological 
factors (e.g., increased hopelessness, rage) to the development of moral injury. As a 
result, veterans appeared to have increased self-blame and self-deprecation that may have 
influenced their development and subsequent recovery from PTSD (Currier, McCormick, 
& Drescher, 2015). Of note, the DSM-5 has now incorporated negative mood and 
emotional states in the conceptualization and diagnoses of PTSD. Taken together, 
research suggests that moral injury and PTSD share many similar cognitive and 
emotional underpinnings, however, further research is needed.  
 
Interventions for Moral Injury 
Presently, no evidence-based treatments exist for moral injury. The etiology of 
moral injury shares similarities to fear conditioning and cognitive models of PTSD but 
are not one and the same (Nash & Litz, 2013). The majority of evidence-based treatment 
models for PTSD are understood through a fear-conditioning paradigm, which may not 
be the origin of moral injury (Drescher et al., 2011). Litz et al. (2009) highlighted the 
need for alternative but complementary models for understanding moral injury and 
traumatic stress. To date there is only one existing model for the treatment of moral 
injury. Litz et al. presented an eight-step model integrating components from existing 
PTSD treatment models including (a) emotional processing of memories related to the 
morally injurious event and (b) exposure to corrective life experiences. The model 
assumes that at the core of one’s moral injury is a deeply held belief that their actions are 
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unforgivable and guilt and shame are deserved. Therefore, exposure to memories related 
to the morally injurious event allows for a corrective emotional experience. Currently, 
this intervention model is being tested as a “modified CBT;” however, no outcomes or 
conclusions have been published at this time (Litz et al., 2009).  
 Intense guilt, shame, and anger are central components of moral injury, and 
avoidance of such emotions contribute to the maintenance of it (Nash & Litz, 2013). In 
addition, moral injury and avoidant behavior persist due to one’s inability to provide self-
forgiveness for breaking one’s moral expectations. Furthermore, moral injury may result 
in self-condemnation. Self-condemnation is the criticism or condemnation of the self as a 
result of engagement in moral wrong doing or violation of one’s moral standards 
(Drescher et al., 2011; Worthington & Langberg, 2012). Taken together, shame, self-
condemnation, and an inability to forgive are contributing factors to avoidant behavior 
associated with moral injury. Thus, targeting avoidance of unwanted internal experiences 
may be a viable treatment approach to target posttraumatic stress associated with moral 
injury. 
 
Evidence-Based Practices for PTSD 
 
A substantial number of evidenced-based treatments exist for PTSD. Exposure-
based behavioral therapies are often considered the gold standard treatment for anxiety 
disorders, including PTSD (Norton & Price, 2007; Olatunji, Cisler, & Deacon, 2010). 
Broadly, treatments under the larger umbrella of Cognitive Behavior Therapy (CBT), 
including treatments possessing exposure components, have the most empirical support 
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for the treatment of PTSD (Foa, Gillihan, & Bryant, 2013). According to Foa et al., most 
cognitive behavioral therapies share two specific aims: (1) to encourage patients to 
confront “safe” trauma reminders, and (2) to disconfirm dysfunctional beliefs that have 
resulted from trauma exposure (Foa et al., 2013). One review indicated that Trauma 
Focused-CBT, which includes components of psycho-education, exposure, and cognitive 
restructuring, has strong support as an effective treatment for PTSD across trauma groups 
(e.g., combat veterans, road traffic accident survivors, refugees, sexual assault victims, 
and terrorism; Harvey, Bryant, & Tarrier, 2003). A notable amount of research supports 
other evidence-based interventions, including prolonged exposure therapy, cognitive 
processing therapy, eye-movement desensitization, and group therapy (Ehlers et al., 
2010; Ehlers & Clark, 2000). 
Prolonged Exposure Therapy (PE) is an exposure-based therapy that consists of 
two primary components- in vivo and imaginal exposure. In vivo exposure requires an 
individual to systematically approach real-life scenarios that they have deemed unsafe. 
Imaginal exposure requires an individual to revisit the traumatic memory through 
systematically narrating the traumatic event (Foa & Rothbaum, 2001; Foa et al., 2013). A 
significant amount of research exists supporting the efficacy of prolonged exposure 
therapy for the treatment of PTSD (e.g., Foa et al., 2005; Foa, Rothbaum, & Furr, 2003; 
Hagenaars, van Minnen, & Hoogduin, 2010; Powers, Halpern, Ferenschak, Gillihan, & 
Foa, 2010). Of note, PE has been found effective in treating veterans who served in the 
OEF/OIF conflicts (Rauch et al., 2010). Cognitive processing therapy (CPT) is a 
therapeutic model that incorporates cognitive restructuring as well as exposure 
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components with the intent of altering cognitive schemas that may be associated with 
exposure to traumatic experience, including safety, trust, power, esteem, and intimacy 
(Resick & Schnicke, 1992). Research has shown substantial support for CPT as an 
efficacious treatment for PTSD (e.g., Resick, Nishith, Weaver, Astin, & Feuer, 2002). 
Additionally, PE, along with CPT, have been “rolled out” as primary interventions for 
PTSD, throughout Veterans Affairs health centers across the country (Garcia et al., 
2011). Eye movement desensitization and reprocessing (EMDR) requires an individual to 
perform a series of saccadic eye movements while simultaneously imagining the trauma 
memory and challenging their negative meaning(s) (Shapiro, 1996). Empirical support 
exists for EMDR as an effective treatment for PTSD, however, it is not superior to 
exposure-based treatments and the necessity of eye-movements remains controversial 
(e.g., Davidson & Parker, 2001; Rothbaum, Astin, & Marsteller, 2005).  
Group treatment is a common evidenced-based approach for the treatment of 
PTSD in health care settings (Foy et al. 2010). A recent meta-analysis examined the 
efficacy of group-based treatments for PTSD. A total of 16 studies with 1,686 individuals 
were treated for PTSD within group settings. Results showed that group treatment was 
efficacious within treatment conditions (d = 0.71), and greater effects were seen for those 
in groups compared to waitlist-control conditions (d = 0.56). However, results showed 
that effect sizes were nonsignificant for group treatment compared to other active 
conditions (d = 0.09). In conclusion, while group treatment is an effective intervention, it 
is not more effective than individual treatment (Sloan et al., 2013).  
Several meta-analyses have assessed the strength of these aforementioned 
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interventions. Overall, meta-analyses have found similar effects sizes across 
psychotherapies for PTSD when compared to no-treatment controls or a 
waitlist/supportive control group (e.g., J. Bisson & Andrew, 2005; J. I. Bisson et al., 
2007; Bradley, Greene, Russ, Dutra, & Westen, 2005; Van Etten & Taylor, 1998). 
Alternatively, to control for treatment variables (e.g., treatment length, outcome 
measures, disorder severity) recent studies have utilized direct-comparison methods 
(Benish, Imel, & Wampold, 2008). One meta-analysis using a direct-comparison method 
found no significant difference between EMDR and exposure-based treatments 
(Davidson & Parker, 2001). Another meta-analysis aimed to provide an overall effect size 
for “bona-fide” treatments of PTSD treatments. Bona-fide treatments are defined as 
treatments that are “meant to be therapeutic” as determined by criteria from Wampold et 
al. (1997). To be classified as bona-fide a treatment had to be delivered by a trained 
therapist, tailored to the individual being treated, and meet two of the four criteria: a) 
provide a reference to an established treatment (e.g., PE) (b) provide a description of the 
therapy and the theory it was derived from (c) provide a treatment manual or (d) provide 
a list of the active treatment components. Therefore, studies with supportive therapies, 
component, and dismantling approaches were excluded. Fifteen studies were included in 
the meta-analysis and met the following criteria: (a) two or more psychotherapy 
comparisons, (b) no classification of treatments into categories, and (c) only included 
bona-fide treatments (e.g., beyond supportive counseling). Benish et al. found that 
between-group effect sizes for both PTSD and outcome measures were uniformly 
distributed around zero. As such, the meta-analysis concluded that “bona fide” treatments 
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for PTSD are equally efficacious (Benish et al., 2008). A critique by Ehlers et al. (2010) 
dispute these findings, suggesting that the meta-analysis introduced bias in their head-to-
head comparisons and failed to signify that treatments are more effective than the natural 
recovery process. Furthermore, Ehlers et al. argued that over two decades of research 
suggests that trauma focused cognitive behavioral therapies are the most efficacious 
treatment for PTSD. 
 
Limitation of Current Treatments  
Importantly, while effective treatments exist for PTSD, such as PE and CPT, a 
percentage of individuals do not respond to these treatments. Dropout rates for CBT vary 
widely, with a range from 0 to 54% (Schottenbauer et al., 2008). A recent review 
examined dropout rates across eight psychotherapy approaches for PTSD. Results 
showed that dropout rates were highest for individuals treated with “full” CBT (28.5%) 
compared to exposure (23.2%), CPT (23.2%) and integrative therapies, including 
relaxation and supportive therapy (8.8%; Swift & Greenberg, 2014). In contrast, another 
meta-analysis compared dropout rates amongst 42 clinical trials for PTSD, including 17 
direct-comparisons. Across all studies, the average dropout rate was 18%. Interestingly, 
within study comparison failed to show a difference in dropout rates amongst trauma-
focused therapies. However, trauma-focused therapies resulted in higher dropout rates 
than present-centered therapy (Imel, Laska, Jakupcak, & Simpson, 2013). A study at a 
specialized VA PTSD clinic examined dropout rates amongst 117 veterans receiving 
variants of CBT (i.e., individual CPT or PE, group CPT, or individual or group CPT + 
PE). Treatment dropout was defined as a veteran discontinuing treatment before they had 
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reached a predetermined treatment goal (e.g., not having PTSD). Of the 117 veterans, 79 
(67.5%) were considered dropouts. Age was a significant predictor in dropout, with 
younger veterans less likely to complete treatment (Garcia et al., 2011). As Garcia et al. 
wrote, “Our most effective treatments are only as good as the patient’s ability to complete 
them” (p.1). In conclusion, notably high dropout rates suggest that further research on 
other viable treatment options is warranted at this time. 
 
Emerging Treatments for PTSD  
 Additional treatment options for PTSD continue to emerge. A recent study offers 
a comprehensive review regarding the efficacy of alternative therapies for PTSD. 
Overall, the review concludes that technology-based interventions, including virtual 
reality exposure and internet-based treatments, have promising data (Cukor, Spitalnick, 
Difede, Rizzo, & Rothbaum, 2009; Schottenbauer et al., 2008). Emerging 
pharmacotherapies aimed at enhancing exposure therapy such as D-cycloserine have 
limited but favorable data for enhancing extinction learning (Davis, Ressler, Rothbaum, 
& Richardson, 2006). Imagery-based therapies including imagery rescripting was shown 
to be effective in augmenting exposure (Arntz, Tiesema, & Kindt, 2007) while imagery 
rehearsal therapy was shown to be effective in treating nightmares amongst veterans (Lu, 
Wagner, Van Male, Whitehead, & Boehnlein, 2009). Notably, a new focus has been 
placed on social and family based therapies such as Cognitive behavioral conjoint therapy 
(Monson, Schnurr, Stevens & Guthrie, 2004) and Family systems therapy for trauma 
(Ford et al., 1998). While research is scant in this area, inclusion of family members in 
the treatment process has a strong theoretical support and warrants future investigation 
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(Cukor et al., 2009). A recent meta-analysis examined the efficacy of writing therapy, 
often referred to as narrative therapy, for the treatment of PTSD. Results showed writing 
therapy to be an efficacious method of treatment compared to a waitlist control for PTS 
and comorbid depression, however when compared to trauma-focused cognitive 
behavioral therapy there was no significant difference. However, findings included in this 
meta-analysis are limited considering that only six studies were included in the analysis 
(van Emmerik, Reijntjes, & Kamphuis, 2012). Several other studies have examined the 
function of behavioral approaches in the treatment of PTSD. Together, research suggests 
that certain behavioral components such as behavioral activation (Jakupcak et al., 2009) 
and introceptive exposure (Wald & Taylor, 2007) are successful additives to therapy but 
should not be utilized as standalone treatments. In conclusion, several emerging 
treatments exist for PTSD, however further research is needed on both the basic 
processes of change as well as the effectiveness of these interventions (Shay, 2014). 
 
Exposure Therapy and Modern CBT 
 
Basic Science Support 
 Many anxiety treatments including exposure therapy originated through support 
from basic science (e.g., Bouton, Mineka, & Barlow, 2001). Basic science suggests that 
exposure therapy is purported to work through fear extinction. This process can be 
understood as a translation of Pavlovian fear conditioning processes-the CS (conditioned 
stimulus) is paired with the U.S. (unconditioned stimulus; Abramowitz, Deacon, & 
Whiteside, 2012). During exposure therapy, the CS is presented without the U.S., often 
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resulting in a decreased response to the CS. As a result, the CS now has two meanings (a) 
CS means U.S. (excitatory pathway-original learning) and (b) CS means no U.S. 
(inhibitory pathway-new learning). Therefore, the original fear memory cannot be erased, 
but instead new learning may occur. This alternative new learning between the 
conditioned and unconditioned stimulus is referred to as inhibitory learning (Bouton, 
1993). In summary, fear learning (acquisition & extinction) has been translated into 
exposure-based treatments.  
For decades, clinicians have relied on fear response during exposure to determine 
treatment progression and success. Recent conclusions suggest that the level of fear 
experienced post exposure is both dependent on the strength of the new learning that 
occurred during exposure and independent of the level of fear displayed during the 
exposure (Craske et al., 2008; Myers & Davis, 2006). However, many of the 
aforementioned evidenced-based treatments rely on fear-exhibited during exposure to 
provide clinical guidance and determine treatment success. Thus, modern approaches to 
PTSD treatment may be more effective by targeting a different mechanism of change 
during exposure therapy. Craske et al. proposed an alternative mechanism of change, that 
is, the toleration of fear or distress during exposure therapy. Research has found that the 
toleration of fear in the presence of the feared stimulus is important to optimizing 
inhibitory learning (Craske et al., 2008; Craske & Mystkowski, 2006). This approach of 
optimizing inhibitory learning suggests that creating “a violation in expectancies,” 
enhances one’s ability to realize that a feared stimulus that resembles threat in fact is not 
threatening (Craske et al., 2008, p. 14). Therefore, as basic science develops, researchers 
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and clinicians alike, continue to examine which treatments models most effectively target 
these processes of change.  
 
Experiential Avoidance and PTSD 
 
In line with the concept that tolerance rather than in-session reduction in fear are 
key factors in the treatment of PTSD, there has been considerable research on the role of 
experiential avoidance in the development and maintenance of PTSD. Experiential 
avoidance is a method of actively avoiding or escaping particular private experiences, 
and is inversely related to overall psychological functioning, such that higher rates of 
experiential avoidance correlate with poorer psychological functioning (e.g., Hayes, 
2004; Walser & Westrup, 2007). Within PTSD, private experiences may include negative 
emotional states, traumatic memories, negative thoughts about oneself, others, or the 
world, and/or distressing physiological reactions. Interestingly, experiential avoidance 
has a paradoxical effect on the development and maintenance of PTSD. On one hand, 
avoidance may temporarily alleviate distress related to the unwanted private experiences 
and provide a sense of control (Burrows, 2013). On the other hand, this avoidance or 
inability to contact the private experience results in a negative reinforcement cycle. 
Ultimately, life becomes about escaping or avoiding distress resulting in notable 
reduction in positive and meaningful life activities (Thompson & Waltz, 2010; Walser & 
Westrup, 2007). 
Researchers have shown that experiential avoidance is significantly correlated 
with posttraumatic symptomology (e.g., Bluett et al., 2014; Plumb, Orsillo, & Luterek, 
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2004). One study examined 160 women who had experienced a sexual assault in addition 
to one or more potentially traumatic events. Contrary to predictions, experiential 
avoidance and general psychiatric symptoms were equivalently associated to 
posttraumatic stress symptoms. However, a particular form of experiential avoidance, 
thought suppression was significantly correlated to posttraumatic stress symptoms (Tull, 
Gratz, Salters, & Roemer, 2004). A group of studies examined the impact of experiential 
avoidance on individuals who have experienced childhood sexual assault. One study in 
particular showed that experiential avoidance played a mediating role between childhood 
sexual assault and distress (Marx & Sloan, 2002). Research has demonstrated that various 
coping strategies, including negative attitudes and thought suppression are related to post-
traumatic symptomology. One study showed that experiential avoidance, determined by 
negative attitudes towards expression of emotions, was predictive of developing PTSD in 
motor vehicle survivors (Nightingale & Williams, 2000) while another study showed 
avoidance strategies being predictive of post-traumatic symptomology amongst Gulf War 
veterans (Benotsch et al., 2000). Given these findings, experiential avoidance appears to 
influence ones’ psychological functioning after experiencing a trauma and likely an 
important objective for treatment (Bluett et al., 2014).  
As reviewed, treatments for PTSD are not universally effective and dropout rates 
amongst veterans are particularly alarming (Garcia et al., 2011). Existing PTSD 
treatments such as PE continue to target fear reduction as a process of change. However, 
research suggests that alternative processes of change, such as tolerance and acceptance, 
might actually be more consistent with the basic research on this topic. Avoidance 
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appears to be a common and predominant theme in the development and maintenance of 
PTSD as well as moral injury. Therefore, a treatment that promotes acceptance and 
decreases avoidance may be effective for the treatment of PTSD and moral injury.  
A recent paper by Thompson, Luoma, and LeJeune (2013) explored the 
relationship between Acceptance and commitment therapy (ACT) and the treatment of 
PTSD. Specifically, the study examined how the principles of ACT both build on 
traditional exposure processes as well as enhance inhibitory learning in the treatment of 
PTSD. The ACT model highlights the importance of moving beyond tolerance of painful 
traumatic memories and the associated internal experiences into acceptance. Acceptance 
is the ability to experience thoughts and feelings as they arise. Thus acceptance creates an 
experience in which new learning may occur. Notably, this model suggests that exposure 
is conducted in order to facilitate valued living rather than symptom reduction (Eifert & 
Forsyth, 2005). 
 
Acceptance and Commitment Therapy 
 
As previously written, experiential avoidance, often results in maintaining or 
increasing the frequency of the unwanted inner experience, in addition to poor 
psychological functioning and a lower quality of life. Alternatively, acceptance-based 
interventions promote willingness to experience thoughts, feelings, and emotions, without 
changing their form, meaning, or frequency; thereby allowing for engagement in life 
regardless of the severity of internal experiences. One such therapy, ACT, has growing 
support as an intervention for anxiety disorders (Arch et al., 2012; Bluett et al., 2014; 
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Ruiz, 2010). The primary focus is to increase behaviors that are consistent with personal 
values while allowing for any given internal experience to be present. This therapeutic 
approach emphasizes the willingness to experience unwanted internal experiences while 
continuing to behave in a way that is consistent with one’s personal values. Therefore, 
ACT aims to alter the function of the thoughts and feelings rather than the content. The 
philosophy and theory of ACT suggest that altering the verbal context in which 
avoidance behaviors are predominant will lead to behaviors in line with personally 
identified values (Hayes, 2004). To provide a more complete understanding of this 
therapeutic approach, a brief overview of the philosophical and theoretical assumptions 
of this model will be presented.  
 
Philosophy of Science 
Functional contextualism, the philosophical underpinnings of ACT, is concerned 
with the actions or events in the context by which they occur (Hayes, 1993; Hayes, 
Hayes, & Reese, 1998). Functional contextualism encompasses several key components. 
One such component indicates that an event must be viewed as a whole event including 
the past and current contexts. A second component emphasizes the pragmatic truth 
criterion of successful working. Successful working is determined by the consistency in 
which the action is in line with one’s values (Hayes, Luoma, Bond, Masuda, & Lillis, 
2006). Finally, the unified goal of functional contextualism is to predict and influence 
such behaviors (Hayes, 2004). Building on this foundation of philosophy of science, ACT 
is grounded in a behavioral theory of language and cognition (Thompson et al., 2013).  
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Relational Frame Theory 
ACT is rooted in behavior analysis including a “contextualistic theory of 
cognition” called relational frame theory (RFT; Hayes, 2004) This theory of human 
language and cognition suggests that humans have the ability to arbitrarily relate events 
both mutually and in combination and those responses are under contextual control 
(Hayes, 2004; Hayes et al., 2006). That is, humans have the ability to respond to both 
internal and external stimuli based on properties that are not directly experienced 
(Twohig, 2009b). Thus, an individual’s relational responding results from a type of 
learning, called relational learning, in which a transformation of stimulus function may 
occur (Hayes, 2004). Ultimately, this transformation of stimulus functions results in the 
function of one stimulus altering the function of another, possibly unrelated in formal 
ways. This relational framing has several clinical implications including the concept of 
experiential avoidance. Specifically, RFT allows fear and avoidance responses from one 
stimulus to transfer to a seemingly unrelated internal or external stimulus through 
relational framing- often leading to psychological inflexibility. For example, during a 
patrol a veteran witnessed an explosion in a garbage can on the street corner. Now 
anything that may be perceived as “hidden,” evokes a fear response in the veteran, which 
results in a large number of stimuli that evoke fear.  
Psychological inflexibility is the inability to accept distressing thoughts, feelings, 
and emotions as they arise, and not engaging in meaningful actions. Conversely, 
psychological flexibility is the ability to contact the present moment by openly accepting 
internal and external experiences by behaving in a way that is consistent with one’s 
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values (Hayes et al., 2006). ACT targets six functional processes in efforts to broaden an 
individual’s psychological flexibility. Independently, the six core processes are effective 
targets of treatment that may be applied through experiential exercises and metaphors in 
order to increase one’s psychological flexibility (Thompson et al., 2013). One primary 
process of ACT, acceptance, is the process of fostering an open, willing attitude, to 
experience one’s thoughts, feelings, and emotions without engaging in avoidance 
(Luoma, Hayes & Walser 2007). Defusion, opposed to fusion, is the act of observing 
one’s thoughts as thoughts, rather than interpreting the content as reality (Luoma et al., 
2007). Written differently, defusion allows a decrease in the literal impact of language 
(Twohig, 2012). Contact with the present moment is being connected to internal and 
external experiences as they occur rather than events in the past or the future. Self as 
context, or the observer-self, is the process of taking a perspective that allows 
differentiation between evaluations of self and the actual self (Thompson et al., 2013). 
Personally chosen values are fundamental areas of life that provide motivation and 
meaning to engage in specific actions (Twohig, 2012). Finally, committed actions are 
behaviors that one participates in order to move toward personally identified values 
(Hayes et al. 2006). Moreover, a recent meta-analysis on laboratory based studies by 
Levin et al. revealed that components of the ACT model (e.g., acceptance and defusion) 
increase psychological flexibility and may increase willingness to engage in a distressing 
task (Levin, Hildebrandt, Lillis, & Hayes, 2012). 
 
  
25 
 
Effectiveness of ACT for PTSD 
 
ACT has gained support as an effective treatment for a variety of anxiety 
disorders (Bluett et al. 2014; Sharp, 2012). While research is limited, an increasing 
numbers of case studies have shown promising results for ACT as an intervention for 
PTSD. To date, four case studies, one multiple baseline, one group study and one 
randomized controlled trial have been conducted utilizing ACT for PTSD.  
A preliminary case study conducted by Batten and Hayes (2005) reported the 
application of ACT for PTSD and comorbid substance abuse in a 19-year old White 
female. Results showed posttreatment improvements through 12-month follow-up, 
providing preliminary data for ACT as a treatment for comorbid disorders along with an 
in depth conceptualization of the application of ACT for PTSD (Batten & Hayes, 2005). 
A second study presented a case of a 51-year-old Vietnam veteran presenting with 
posttraumatic stress and depressive symptoms who refused exposure therapy. The veteran 
willingly participated in an ACT protocol and actively engaged in committed actions 
associated with his personal values (Orsillo & Batten, 2005). A third case study presented 
the treatment of a 43-year-old White female with a comorbid diagnosis of PTSD and 
depression. Two months prior the individual failed to respond to 20 sessions of traditional 
CBT for trauma from a history of physical and verbal abuse. In this case study she 
received 21 sessions of ACT. Results showed clinically significant decreases in her 
PTSD, depression, and anxiety symptoms. Notably, her scores on the PLC-C, a measure 
of PTSD symptoms, decreased from a 67 at time of intake to a 28 at posttreatment, close 
to one standard deviation below the clinical cutoff for PTSD. Additionally, scores on the 
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BDI-II dropped from a 34 pretreatment to a 4 posttreatment, as well as decreases on the 
BAI, reducing from a 38 to 7 by posttreatment. Furthermore, the individual displayed 
notable decrease on a measure of psychological flexibility, with AAQ scores decreasing 
by 43% from pre- to posttreatment. Interestingly, scores on the PTCI, a measure of 
trauma-related thoughts and beliefs, only showed a decrease from sessions 16-21, a point 
in treatment in which PTSD symptoms, measured by the PLC-C had decreased by 50% 
(Twohig, 2009a).  
A recent case study examined the effectiveness of 18, 50-minute, ACT treatment 
sessions for an 18-year old female with sexual assault trauma (Burrows, 2013). The early 
phases of treatment focused on creating present moment awareness, decreased avoidance 
of sleeping, as well as defusion from her thoughts. The middle stages of treatment 
targeted avoidance and conceptualization of the self. In the final stages of treatment, the 
client continued to work on defusion and acceptance of anxiety, creating a personal 
metaphor as anxiety being “a dragon that she had to create space for.” Results from this 
study showed improvements on the primary measure of experiential avoidance, AAQ-II, 
36 pretreatment, 26 at the final treatment session, and 26 at an 8- month follow-up. 
Thought suppression measured by the White Bear Suppression Inventory decreased from 
73 at pretreatment to 57 at posttreatment, and to 48 at 8-month follow-up. The individual 
displayed significant reductions in trauma symptoms as measured by the Trauma 
Symptom Checklist with a score of 70 at pretreatment to a score of 45 at the final session 
and 35 at an 8-month follow-up. Notably the study showed improvements on the VLQ 
(valued living questionnaire). Finally, one study has been conducted utilizing ACT for 
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adolescents with posttraumatic stress (PTS). A multiple-base line design was utilized to 
treat seven adolescents with PTSD (four in the community and three at a residential 
treatment setting). Results showed preliminary support for ACT with a 73.7% mean 
reduction in self-reported PTSD symptoms and nearly 60% mean reduction in clinician 
rated measures of PTSD (Woidneck, Morrison & Twohig, 2014). 
To our knowledge, ACT has been applied once in a group treatment setting for 
veterans (Williams, 2007) and larger unpublished randomized-control trial treating 
veterans for trauma related stress. However, to date no data is available regarding the 
finding of these studies. 
In summary, PTSD is a paramount issue amongst U.S. active service members 
and veterans. Additionally, moral injurious events may be directly related to the 
development and maintenance of extreme psychological distress, such as PTSD, in U.S. 
military personal and veterans. While evidence-based treatments for PTSD exist, they are 
not universally effective. Additionally, purported mechanisms of change from these 
existing treatment models have shifted with recent research. Specifically, a model of 
toleration or acceptance may be a more viable approach for treating PTSD than fear 
reduction. Thus, acceptance and mindfulness-based interventions have promising 
implications as an alternative or second line intervention for PTSD amongst veterans. For 
these reasons, the investigation of ACT as a next-step intervention for veterans with 
chronic PTSD is warranted.  
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CHAPTER III 
 
METHODS 
 
 
Design 
 
 
 This study implemented an 8-week group intervention to examine the 
effectiveness of ACT for Veterans diagnosed and previously treated for PTSD. A group 
intervention was advantageous considering the continual need for mental health services 
for veterans with PTSD (e.g., Sripada et al., 2016). Enrollment for this study was 
continuous; however, a closed-group design was utilized (i.e., veterans were only allowed 
to join a group at the beginning of an 8-week group cycle). In total four, 8-week groups 
were conducted between June 2015 and May 2016, in the PTSD Clinic at the George E. 
Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, Utah.  
 Participants were referred by their provider, but ultimately self-selected to join the 
group. The intended sample size for this study was 40 participants total, with a minimum 
of 5 veterans per group. This number was determined by an initial power analysis 
conducted through G*Power software with an alpha level of .05 and a power of .80. The 
preliminary power-analysis, using an effect size of .25, specified a sample of 28. An 
actual sample of 33 participants was enrolled.  
 
Participants 
 
 Approximately 49 veterans were referred to participate in the group. Of those 
referred, a total of 33 veterans enrolled in the study. Several veterans referred to the 
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group were unable to participate due to work schedules, the time and day of the group, 
and transportation. Many requested to be contacted for the next group. Three of the 
referred veterans indicated that they were uninterested in participation.  
To be eligible to participate in the group, veterans had to meet the following 
criteria: (1) the veteran must have been over the age of 18, (2) the veteran must have been 
diagnosed with PTSD or subclinical PTSD, and (3) the veteran must have enrolled and 
completed an evidenced-based treatment for PTSD. An initial diagnosis for PTSD or 
subclinical PTSD was determined through an official in-person psycho-diagnostic 
assessment conducted by a member of the PTSD Specialty Clinic at the Salt Lake City 
Veterans Affairs Medical Center. For this study, diagnostic status was reassessed and 
determined by the PCL-5. Additionally, veterans must have completed an evidenced-
based treatment for PTSD prior to participation in the group. Evidenced-based treatments 
for PTSD include prolonged exposure therapy, cognitive processing therapy, and eye 
movement desensitization and reprocessing. Participants were excluded if they (1) were 
currently enrolled in an EBT group treatment, (2) were experiencing psychosis, or (3) 
experienced a cognitive disability that would inhibit their ability to participate in the 
study. The study was approved by the Institutional Review Boards at the University of 
Utah and Utah State University as well as the SLC Veteran Affairs Office of Research.  
 
Procedure 
 
Recruitment 
Veterans were recruited through referrals from mental health providers at the VA 
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(see Appendix A). In order to maximize referrals, announcements regarding the group 
were made during weekly team meetings for therapists on the PTSD team. In addition, 
flyers were posted throughout the VA campus and the community. All referrals by mental 
health providers were added to the ongoing recruitment list. Referred veterans were 
contacted by telephone one month prior to a projected group start date. Study personal, 
invited veterans to participate in the group, provided information regarding the goals and 
therapeutic approach of the group, and answered any questions or concerns posed by the 
potential participants. Veterans uninterested in the group were offered referrals and those 
unable to attend were rolled over to the next group’s referral list.  
Veterans who were interested in the group were invited to attend the first session. 
All groups were held in a group room in Building 16 on the George E. Wahlen 
Department of Veterans Affairs Medical Center campus. The group was conducted by 
Ellen Bluett, a graduate student at Utah State University, Dr. Brandon Yabko, Dr. James, 
Asbrand, and Dr. Sara Owen - staff psychologists at the Salt Lake City, Veterans Affairs.  
At session one, individuals were provided information regarding the option to 
participate in the research study. A verbal announcement was made regarding the purpose 
of the research. All interested veterans were provided an informed consent cover letter-
which outlined the details of the study, including risk and benefits of participation, 
confidentiality, and data collection. Prior to data collection, all remaining questions were 
answered and study personal clearly stated that veterans could participate in the group 
without participating in the research study. All veterans who attended the first session 
agreed to research participation.  
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Data Collection and Storage  
Once consented, veterans were asked to complete a pretreatment assessment 
battery, which included a well-established measure of PTSD, overall functioning, 
distress, and background information (see Measures section). To ensure confidentiality, 
each veteran was provided a unique participant ID number, which was used throughout 
the course of the research study. All identifying information for the veteran was kept 
separate from the study data.  
Assessment measures were provided in paper and pencil format (Appendix B). 
Assessment procedures are outlined in Table 1. To determine the effectiveness of the 
group intervention, data was collected at three time-points including pretreatment 
(session 1), posttreatment (session 8), and follow-up (1-month). Pretreatment assessments 
were collected prior to the start of session one and posttreatment assessment measures 
were collected at the end of session eight. In addition, due to time constraints and an 
awareness of participate burden, a comprehensive background information packet was 
administered at the end of session 1. Veterans were asked to complete and return the 
packet at the next session. One month after the final treatment session, veterans were sent 
a follow-up questionnaire packet in the mail, along with a pre-addressed, pre-paid 
envelope. Veterans were asked to complete the follow-up questionnaire packet and return 
it to the VA. To assess for processes of change, participants were asked to complete two 
measures (AAQ-II, VQ) at the end of session three and session six. Finally, treatment 
integrity measures were administered at the end of each session in efforts to assess for 
treatment adherence by study personal (Appendix B).  
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Table 1 
Assessment Timeline  
 
 Week 1 Week 3 Week 6 Week 8  Week 12 
Pretreatment  Acceptance and Action 
Questionnaire-II , Valuing 
Questionnaire 
Acceptance and Action 
Questionnaire-II , Valuing 
Questionnaire 
Posttreatment  Follow-Up 
 
Treatment 
 The treatment administered was an adaptation of a pre-existing ACT manual 
developed for adult individuals with PTSD (Walser & Westrup, 2007). The original 
protocol was modified to best fit a group format for veterans. Because the focus of this 
group was not on trauma processing, the trauma-processing components were excluded 
from this treatment. Treatment consisted of 8-weekly, 2-hour sessions of group therapy, 
which followed the ACT protocol. The aims of the treatment protocol included (1) 
increasing psychological flexibility, (2) decreasing experiential avoidance, and (3) 
increasing behaviors that were consistent with self-identified values. The full treatment 
manual used for this study can be found in Appendix D.  
Table 2 includes a brief overview of the treatment components and exercise 
covered at each treatment session. After session one, each session followed a similar 
format. The sessions began with a mindfulness exercise and check-ins regarding 
behavioral commitments. The majority of each session was spent introducing a treatment 
component with accompanying metaphors/experiential activities. Each session ended 
with each veteran setting a new behavioral commitment for the week.  
 
33 
 
Table 2 
ACT for Posttraumatic Stress  
Session Treatment components Exercises/content 
1 Informed consent   
Confidentiality and group 
rules 
Rules/guidelines introduced to help participants feel safe and comfortable 
in the group.  
Vitality, values  Focus of treatment is not on symptom reduction or trauma processing, 
instead focus on doing what matters. ACT is a radically different approach 
than CPT, PE, EMDR.  
 Clipboard Metaphor  
Goal of therapy: Triflex model of Vitality: doing what matters, being 
present, and willingness.  
2 Mindfulness/present moment Breathing meditation  
 Creative hopelessness  Explored past attempts to control, alter, change certain PTSD symptoms; 
Examined cost and effectiveness of trying to control, alter, change. PTS 
symptoms.  
 Creative Hopelessness  
 Behavioral commitment  Set weekly goal linked to a valued domain  
3 Mindfulness & check-in Progressive Muscle Relaxation  
 Control as the problem/ 
willingness  
Reviewed the paradoxical effect of trying to control thoughts feelings 
emotions.  
 Man in the Hole 
Discussed why humans try to control thoughts, feelings, emotions 
Introduced alternative to control. 
 Tug of War  
 Behavioral commitment Set weekly goal linked to a valued domain 
4 Mindfulness & check-in Welcome Anxiety My Old Friend  
Willingness Introduced the concept of willingness- the opposite of control/avoidance-
Finger-trap, Annoying Uncle Bob, Perfect anxiety detector  
Behavioral commitment  Set weekly goal linked to a valued domain 
5 Mindfulness & check-in Leaves on a stream  
 Defusion Discussed fusion vs. defusion; Discussion on our “programming” and not 
taking our thoughts literally or as “Truth” 
 2 computers, Milk, Milk, Milk  
 Behavioral commitment  Set weekly goal linked to a valued domain 
6 Mindfulness & check-in Take your mind for a walk  
Defusion Reviewed handouts from the “Happiness Trap” in order to increase 
cognitive defusion, words and thoughts are just words and thoughts.  
Behavioral commitment  Set weekly goal linked to a valued domain 
(table continues)
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Session Treatment components Exercises/content 
7  Mindfulness & check-in Self-compassion exercise  
 Self-as-context Introduced the concept of the observer self and the concept that you are 
not your thoughts. 
 Chessboard Metaphor 
  Set weekly goal linked to a valued domain 
8 Mindfulness & check-in  
 Acceptance, values Reviewed concepts that you can move towards your values with 
passengers on your bus (thoughts, feelings, emotions) 
 Passengers on a Bus 
 Maintenance  Bill of Rights 
 Post-assessment   
Note. Italicized items are metaphors or exercises published in Walser & Westrup (2007). 
 
Measures 
Diagnostic Measures 
Background/Demographics. The background information form collected baseline 
demographics about the veteran including sex, age, marital status, educational history, 
medication, previous treatment, and basic military characteristics (e.g., era, branch).  
 
Outcome Measures 
PTSD Checklist (Blanchard, Jones-Alexander, Buckley, & Forneris, 1996; 
Weathers, Litz, Herman, Huska, & Keane, 1993). The PTSD Checklist (PCL-5) is a self-
report measure that is intended to screen for PTSD. Items are reported on a 4-point Likert 
scale 0 (not at all) to 4 (extremely bothered). The PLC-5 measure is used during clinical 
assessment to evaluate the validity of symptoms endorsed via self-report. Items rated a 2 
or above are considered significant symptoms and considered meeting diagnostic criteria. 
The cutoff method indicates that a score of 38 or above on the PCL-5 meets diagnostic 
criteria for a PTSD diagnosis. Cronbach’s alpha for this study was α = .92. 
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Patient-Health Questionnaire (Beck, Steer, & Brown, 1996). The Patient Health 
Questionnaire (PHQ-9) is a commonly used brief self-report measure assessing for 
depression. The measure specifically assesses for depressive symptoms that are derived 
from the diagnostic criteria for Major Depressive Disorder. The 9-item measure is scored 
on a 4- point Likert scale assessing frequency of symptoms ranging from 0 (not at all) to 
3 (nearly every day) Scores range from 0 to 27 with higher scores signifying greater 
depression. Symptom severity cut-off scores have been established into the following 
categories: 0-4 (no depression), 5-9 (mild depression), 10-14 (moderate depression), 15-
19 (moderately severe depression) and scores from 20-27 (severe depression). The 
measure has been found to have good internal consistency (α = 0.86-0.89) and excellent 
test-retest reliability (r =.81-.96; Löwe, Unützer, Callahan, Perkins, & Kroenke, 2004; 
Sripada et al., 2016). Cronbach’s alpha for this study was α = .88.  
World Health Organization Well-Being Index (WHO-5; Beck et al., 1996). The 
WHO-5 is a self-report measure assessing well-being over the past two weeks. The 5-
item measure is scored on a 6-point Likert scale ranging from 0 (at no time) to 4 (all of 
the time). Scores range from 0 to 25 with higher scores signifying greater well-being. A 
percent may be calculated by multiplying the total score by 4—a percentage of 0 equals 
the worst possible well-being and a percentage of 100 equals the best possible well-being. 
The measure has been found to have good internal consistency (α = .84; Bech, Olsen, 
Kjoller, & Rasmussen, 2003). Cronbach’s alpha for this study was α = .84. 
Internalized Shame Scale (ISS; Cook, 1996). The ISS is a 24-item self-report 
assessment that measures internalized shame, an emotion of negative self-evaluation, is 
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rated on a 5-point Likert scale ranging from 0 (never) to 4 (almost always) (del Rosario & 
White, 2006). An additional 6-items assessing self-esteem are often included in this 
measure. The measure has shown to have good internal consistency ranging from a 
clinical sample (α = .87 to α = .90; Rybak & Brown, 1996) and good test-retest 
reliability, (r = .81; del Rosario & White, 2006). Cronbach’s alpha for this study was α = 
.96. 
Quality of Life Scale (Burckhardt, Woods, Schultz, & Ziebarth, 1989). The 
Quality of Life Scale is a measure that determines overall life satisfaction. This 16-item 
questionnaire requires an individual to rate areas of satisfaction (e.g., close friends) on a 
7-point Likert scale, 1 (terrible) to 7 (delighted). Total scores indicate current quality of 
life with higher scores being associated with better quality of life. This measure has 
shown both good internal consistency (α = .89 and α =.92) and good test-retest reliability 
(r =.78-.84; Burckhardt et al., 1989). Cronbach’s alpha for this study was α = .92. 
Moral Injury Events Scale (MIES; Nash et al., 2013). The MIES is a measure of 
the number of exposures to events perceived to violate moral beliefs or betrayal by 
oneself or another person. This 9-item measure is scored on a 6-point Likert scale, 1 
(strongly agree) to 6 (strongly disagree). Higher scores indicate a greater number of 
morally injurious events experienced. A preliminary psychometric validation study 
examined responses on the MIES 1 week and 3 months post deployments in a sample of 
533 Marines. Test-retest reliability was not found to be statistically significant. Results 
showed excellent internal consistency (α = .90). Importantly the MIES showed 
discriminant validity (r =.08) from the CES (a measure of combat exposure), thus 
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confirming that morally injurious events may occur independent from combat exposure. 
As predicted the MIES was positively correlated with the BDI-II (r = .40) and the PTSD 
checklist (r = .28). Cronbach’s alpha for this study was α = .83. 
Valuing Questionnaire (VQ; Smout, Davies, Burns & Christie, 2014). The VQ is 
a self-report measure assessing values-driven behaviors over the past week. This 10-item 
measure is scores on a 7-point Likert scale and consists of two factors: (a) progress and 
(b) obstruction. The progress subscale measures to what extent an individual engaged in 
behaviors that are consistent with personal values over the past week. The obstructed 
subscale measures to what extent cognitions and emotions prohibited values consistent 
behavior over the past week. Both the progress and obstructed subscales have shown 
good internal consistency (0.86) and (0.83), respectively. Cronbach’s alpha for this study 
was α = .77 for progress and α = .72 for the obstructed subscale.  
 
Process of Change Measures  
The Acceptance and Action Questionnaire-II (AAQ-II; Bond et al., 2011). The 
AAQ-II is a seven-item self-report measure that assesses experiential avoidance and 
psychological flexibility. This 7-item Likert scale, 1(never true) to 7 (always true). It is 
the only existing measure that directly measures experiential avoidance. Higher scores 
indicate greater psychological inflexibility. While no established cutoff exists, total 
scores between 24-28 suggest greater psychological flexibility and less experiential 
avoidance. The AAQ-II has shown good test-retest reliability (r = .81) as well as good 
internal consistency (α = .78 to 87). Cronbach’s alpha for this study was α = .94. 
Believability of Anxious Feelings and Thoughts (BAFT; Herzberg et al., 2012). 
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The BAFT is a 16-item self-report measure of cognitive fusion for anxious thoughts, 
feelings, and bodily responses. The BAFT has shown good internal consistency amongst 
an undergraduate sample (α = .90) and a highly anxious sample (α = .91). Additionally, 
the measure has good test-retest reliability over a 12-week period (r = .77). Cronbach’s 
alpha for this study was α = .95 for the total scale.  
 
Treatment Acceptability 
Treatment Evaluation Inventory Short-Form (TEI-SF; Kelley, Heffer, Gresham, 
& Elliott, 1989). The TEI-SF is a 7–item self-report questionnaire assessing treatment 
acceptability. The original TEI-SF was a 9-item measure; however, two items have been 
excluded as they do not apply to the population within this study. This questionnaire is 
measured on a 5-point Likert scale ranging from 0 (strongly disagree) to 5 (strongly 
agree). Scores are totaled and those above a 21 indicate a greater amount of treatment 
acceptability. The original TEI-SF has shown good internal consistency (α = .85).  
 
Treatment Integrity/Adherence/Fidelity 
 
 The Veterans Affairs follows government security and confidentiality procedures, 
therefore video and audio recording of sessions was not possible for this study. To 
determine treatment adherence, a checklist was administered at the end of each session to 
assess whether each treatment objective was covered in session. Veterans were required 
to circle “yes,” “no,” or “not sure” to indicate whether each treatment objective was 
covered during that session. Total scores and percentages were calculated for each 
treatment session, across the four treatment groups.  
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While treatment adherence options were limited, treatment checklists were 
administered at the end of each session. Results showed that according to veterans across 
groups: 93.75% of the proposed material was covered at session 1, 95.65% at session 2, 
95.5% at session 3, 90% at session 4, 97% at session 5, 95% at session 6, 100% at session 
7, and 97% at session 8. Overall, treatment adherence ratings were above 90% across all 
groups and all sessions. 
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CHAPTER IV 
 
RESULTS 
 
 
Data Analytic Strategy 
 
 
 First, the participant flow was prepared. Second, independent sample t test and 
chi-square analyses were conducted to determine equivalence between treatment 
completers and non-completers on pretreatment variables including demographics, 
military specific demographics, and primary outcome variables. Third, to assess response 
to treatment - change scores were calculated on the PCL-5 from pretreatment to 
posttreatment. Fourth, to assess change on primary outcomes and secondary outcomes 
over time, a series of univariate analyses of variance (ANOVAs) were conducted. Fifth, 
correlations were calculated between pretreatment primary and secondary variables to 
assess associations between these variables. Sixth, to examine whether pretreatment 
symptoms predicted change on PTSD symptoms—simple logistic regressions were 
performed. Seventh, bivariate correlations were conducted to examine the relationship 
between process of change measures (pretreatment to mid-treatment) and posttreatment 
PTSD symptom severity. The analyses for this study were performed utilizing SPPS 
Version 23.0 and MPlus Version 7.0. Visual graphs were prepared utilizing R statistical 
package. 
 
Missing Data 
The dropout rate amongst group participants (42%) was on par with the national 
average for PTSD treatments. Dropout rates for PTSD treatment—without a specific 
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trauma focused component—ranged between 0-48% (Imel et al., 2013) and between 12-
39% (Steenkamp & Litz, 2013). A meta-analysis estimated the average dropout from 
individual treatment for PTSD to be 18%, with group therapy increasing the dropout rate 
by 12% (Imel et al., 2013). While other studies suggest that attrition rates are lower for 
trauma-focused groups compared to individual therapy (Barrera, Mott, Hofstein, & Teng, 
2013).  
 Because of the large amount of dropout from pretreatment to posttreatment to 
follow-up, missing data were handled through multiple imputation in Mplus (Version 7.0; 
Muthén & Muthén, 2012). The Mplus statistical package can produce multiple 
imputations of missing data through Bayesian analysis -which results in multiple data sets 
for analysis (Muthén & Muthén, 2012). Each imputed data set has a unique set of 
replacement values for missing data. For this study, five imputed data sets were created 
with 10,000 iterations. Following imputation, the data was visually scanned for negative 
values, missingness, and values outside the range of the measure, none of which were 
detected. Total scores from each imputed data file were summed and averaged across the 
five models. The mean obtained was used in subsequent analyses. It is important to note 
that while multiple imputation is a viable statistical approach for missing data, precaution 
should be taken in interpreting the data, as there was a small sample size and nearly 40% 
of the study data was missing at posttreatment. 
Overall missing data across each study variable was low (<5%). In the rare 
occurrence of missing data on an item of a study variable- those measures with less than 
10% of the items missing, a mean score and total score was computed for that measure 
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using data points that were present.  
 
Test of Normality and Outliers  
 Tests of normality were conducted on all study variables. Of the outliers detected, 
all were associated with one participant. This participant reported experiencing a 
significant amount of depression, during the course of treatment, and reported elevated 
scores compared to the rest of the sample. Due to the exploratory nature of this study this 
veteran’s data was included in the analyses.  
 
Participant Flow 
 
Approximately 49 individuals were referred to the study. Initially 33 attended 
session one and completed the pretreatment assessment. At session two, 30 individuals 
remained in treatment. Nineteen individuals completed the posttreatment assessment. Of 
note, a majority of the sample completed more than half of the treatment with 24 
individuals completing session 5. Table 3 displays the number of participants remaining 
in the study at each session. Finally, 12 individuals completed 1-month follow-up 
questionnaires. Figure 1 displays the flow of participants across the course of the 12-
week study. 
 
Table 3 
Number of Participants Remaining in Treatment by Session 
 
 Session 
1 
Session 
2 
Session 
3 
Session 
4 
Session 
5 
Session 
6 
Session 
7 
Session 
8 
Participants 33 30 27 25 24 23 20 19 
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Figure 1. Participant flow. 
 
Participant Characteristics 
A summary of participant characteristics for the total sample is provided in Table 
4. Of the 33 participants in this study a majority were male 87.9% (n = 29). The mean age 
of the sample was 49.6 (16.31) with ages ranging between 24 and 70 years old. A 
majority of participants identified as White 84.8% (n = 28). A majority of the sample was 
married 72.7% (n = 24). Furthermore, a majority of the sample was educated with some 
college 30.3% (n =10), an associate’s degree 27.3% (n = 9) or a bachelor’s degree, 21.2% 
(n = 7).  
 
Military Characteristics 
A summary of participant’s military characteristics is presented in Table 5. Of the 
thirty-three participants enrolled in the study 51.5% were OEF/OIF veterans (n = 17) 
36.4% were Vietnam veterans (n = 12), 6.1% were Desert Storm veterans (n = 2), and 
6.1% served in more than one era of war (n = 2). Veterans varied in their military branch; 
45.5% were in the Army (n = 15), 21.2% were in the Marines (n = 7), 9.1% were in the 
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Air Force (n = 3), 9.1% were in the Army Reserves (n = 3), 6.1 % were in the Navy (n = 
2), 6.1% were in the Army National Guard (n = 2) and 3.0% were in the Air Force 
Reserves (n =1). The number of years in service also varied, with a majority of veterans 
serving between one and 5 years (42.4%; n = 14), 36.4% serving between 6 and 10 years 
(n = 12), 6.1% serving between 11 and 15 years (n = 2) and 15.2% serving 21 years or 
more in service (n = 5). Of the veterans enrolled in the study, a majority served one 
deployment 60.6% (n = 20), 8% served two deployments (n = 8), while 15.2% served 
three or more deployments (n = 5). All but three individuals (9.1%) were service 
connected, which indicated that they received some financial compensation for disability 
from the Veterans Affairs Administration.  
 
PTSD Diagnostic Status and PTSD  
Treatment Summary 
The PCL-5 serves a variety of purposes including monitoring symptom change 
over the course of treatment, screening individuals for PTSD, and making preliminary 
diagnoses of PTSD. To determine diagnostic status, the guidelines for the PCL-5 were 
followed. That is, an item rated a “2” or greater was considered an endorsed symptom. To 
meet criteria for a provisional PTSD diagnosis individuals must have endorsed: one 
cluster B item (items 1-5), one cluster C item (items 6-7), two cluster D items (items 8-
14), and two cluster E items (15-20) on the PCL-5 self-report measure. While all of the 
veterans enrolled in the study had received a prior diagnosis of PTSD, 78.8% (n = 26) 
met criteria at session one, while the other 21.2% (n = 7) met criteria for subclinical 
PTSD. All veterans enrolled in the study had enrolled and completed an evidenced-based 
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treatment for PTSD, 60.6% (n = 20) completed CPT, 36.4% (n = 12) completed PET, and 
only one veteran completed EMDRT.  
 
Completer Versus Dropout Differences 
 
Summary of Demographic by Completer  
Status  
To examine differences in demographic characteristics between treatment 
completers and noncompleters, independent sample t tests and chi-squares were 
conducted. Results are shown in Table 4. As can be seen, there appeared to be no 
statistical difference in age, gender, race and ethnicity, marital status, education, 
employment, or religion between completers and noncompleters. Therefore, to our 
knowledge, there is no evidence of treatment dropout based on these variables. Last, no 
adjustments to the data were made.  
 
Summary of Military Characteristics by  
Completer Status 
 
To examine differences in military demographic characteristics between treatment 
completers and non-completers, independent sample T-tests and chi-squares were 
conducted. The results are presented in Table 5. Again, there appeared to be no statistical 
difference in PTSD diagnostic status, era, number of deployments, number of years in 
service, or type of PTSD treatment previously received. From these analyses, there no 
evidence suggests that treatment dropout was related to these variables, therefore no 
adjustments to the data were made. 
 
 Ta
bl
e 
4 
Su
m
m
ar
y 
of
 D
em
og
ra
ph
ic
 S
ta
tis
tic
s b
y 
C
om
pl
et
er
 S
ta
tu
s  
 
 
C
om
pl
et
ed
 (n
 =
 1
9)
 
──
──
──
──
──
──
──
──
─ 
 
D
ro
po
ut
 (n
 =
 1
4)
 
──
──
──
──
──
──
──
──
─ 
 
To
ta
l (
n 
= 
33
) 
──
──
──
──
──
──
──
──
─ 
 
 
C
ha
ra
ct
er
is
tic
 
n 
%
 
M
 
SD
 
n 
%
 
M
 
SD
 
n 
%
 
M
 
SD
 
χ² (
df
) o
r t
 (d
f) 
p 
G
en
de
r 
 
 
 
 
 
 
 
 
 
 
 
 
.5
7(
1)
 
.6
2 
 
M
al
e 
16
 
84
.2
 
 
 
13
 
92
.9
 
 
 
29
 
87
.9
 
 
 
 
 
 
Fe
m
al
e 
 
3 
15
.8
 
 
 
1 
7.
1 
 
 
4 
12
.1
 
 
 
 
 
A
ge
 (y
ea
rs
) 
 
 
53
.2
6 
15
.5
5 
 
 
45
.5
 
16
.3
1 
 
 
49
.6
 
16
.3
1 
-1
.4
 (3
1)
 
.7
2 
Ed
uc
at
io
n 
 
 
 
 
 
 
 
 
 
 
 
 
4.
7 
(5
) 
.4
5 
 
H
ig
h 
Sc
ho
ol
/G
ED
 
4 
21
.0
 
 
 
1 
7.
1 
 
 
5 
15
.2
 
 
 
 
 
 
So
m
e 
C
ol
le
ge
 
4 
21
.0
 
 
 
6 
42
.9
 
 
 
10
 
30
.3
 
 
 
 
 
 
A
ss
oc
ia
te
s  
6 
31
.6
 
 
 
3 
21
.4
 
 
 
9 
27
.3
 
 
 
 
 
 
B
ac
he
lo
rs
 
3 
15
.8
 
 
 
4 
28
.6
 
 
 
7 
21
.2
 
 
 
 
 
 
So
m
e 
G
ra
du
at
e 
1 
5.
3 
 
 
0 
0 
 
 
1 
3.
0 
 
 
 
 
 
M
.A
./M
.S
. 
1 
5.
3 
 
 
0 
0 
 
 
1 
3.
0 
 
 
 
 
M
ar
ita
l S
ta
tu
s 
 
 
 
 
 
 
 
 
 
 
 
 
2.
30
 (3
) 
.4
6 
 
Si
ng
le
 
2 
10
.5
 
 
 
2 
14
.3
 
 
 
4 
12
.1
 
 
 
 
 
 
M
ar
rie
d 
14
 
73
.7
 
 
 
10
 
71
.4
 
 
 
24
 
72
.7
 
 
 
 
 
 
D
iv
or
ce
d 
2 
10
.5
 
 
 
0 
0 
 
 
2 
6.
1 
 
 
 
 
 
Se
pa
ra
te
d 
1 
5.
3 
 
 
2 
14
.3
 
 
 
3 
9.
1 
 
 
 
 
(ta
bl
e 
co
nt
in
ue
s)
 
46
 
  
 
C
om
pl
et
ed
 (n
 =
 1
9)
 
──
──
──
──
──
──
──
──
─ 
 
D
ro
po
ut
 (n
 =
 1
4)
 
──
──
──
──
──
──
──
──
─ 
 
To
ta
l (
n 
= 
33
) 
──
──
──
──
──
──
──
──
─ 
 
 
C
ha
ra
ct
er
is
tic
 
n 
%
 
M
 
SD
 
n 
%
 
M
 
SD
 
n 
%
 
M
 
SD
 
χ² (
df
) o
r t
 (d
f) 
p 
Em
pl
oy
m
en
t 
 
 
 
 
 
 
 
 
 
 
 
 
1.
68
 (4
) 
.8
0 
 
U
ne
m
pl
oy
ed
 
4 
21
.1
 
 
 
3 
21
.4
 
 
 
7 
21
.2
 
 
 
 
. 
 
Pa
rt 
Ti
m
e 
1 
5.
3 
 
 
1 
7.
1 
 
 
2 
6.
1 
 
 
 
 
 
Fu
ll 
Ti
m
e 
4 
21
.1
 
 
 
5 
35
.7
 
 
 
9 
27
.3
 
 
 
 
 
 
D
is
ab
ili
ty
 
4 
21
.1
 
 
 
3 
21
.4
 
 
 
7 
21
.2
 
 
 
 
 
 
R
et
ire
d 
6 
31
.6
 
 
 
2 
14
.3
 
 
 
8 
24
.2
 
 
 
 
 
R
ac
e/
et
hn
ic
ity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B
la
ck
 
1 
5.
3 
 
 
0 
0.
0 
 
 
1 
3.
0 
 
 
1.
76
 (3
) 
.6
2 
 
W
hi
te
 
15
 
78
.9
 
 
 
13
 
92
.9
 
 
 
28
 
84
.8
 
 
 
 
 
 
H
is
pa
ni
c 
2 
10
.5
 
 
 
1 
7.
1 
 
 
3 
9.
1 
 
 
 
 
 
Pa
ci
fic
 Is
la
nd
er
 
1 
5.
3 
 
 
0 
0.
0 
 
 
1 
3.
0 
 
 
 
 
R
el
ig
io
n 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.
9 
(3
) 
.9
0 
 
LD
S 
6 
31
.6
 
 
 
4 
21
.4
 
 
 
9 
27
.3
 
 
 
 
 
 
C
at
ho
lic
 
2 
10
.5
 
 
 
2 
14
.3
 
 
 
4 
12
.1
 
 
 
 
 
 
Pr
ot
es
ta
nt
/C
hr
is
tia
n 
4 
21
.1
 
 
 
4 
28
.6
 
 
 
8 
24
.2
 
 
 
 
 
 
N
ot
 S
pe
ci
fie
d 
7 
36
.8
 
 
 
5 
35
.7
 
 
 
12
 
36
.4
 
 
 
 
 
  
47
48 
 
Table 5 
 
Summary of Military Statistics by Completers versus Noncompleters 
 
 Completed 
(n = 19) 
────── 
Dropout 
(n = 14) 
────── 
Total  
(n = 33) 
──────   
Characteristic n % n % n % χ² (df) or t (df) p 
Era       2.70(4) .61 
 Desert Storm 1 5.3 1 7.1 2 6.1   
 Desert Storm & OEF/OIF 1 5.3 0 0.0 1 3.0   
 OEF/OIF 8 42.1 9 64.3 17 51.5   
 Vietnam 8 42.1 4 28.6 12 36.4   
 Vietnam & OEF/OIF 1 5.3 0 0.0 1 3.0   
Deployments       .28(3) .96 
 One 11 57.9 9 64.4 20 60.6   
 Two  5 26.3 3 21.4 8 24.2   
 Three 2 10.5 1 7.1 3 9.1   
 Four  1 5.3 1 7.1 2 6.1   
Years in service       2.60(3) .46 
 1-5 9 47.4 5 35.7 14 42.4  . 
 6-10 5 26.3 7 50.0 12 36.4   
 11-15 1 5.3 1 7.1 2 6.0   
 16-20 0 0.0 0 0.0 0 0.0   
 > 21 4 21.0 1 7.1 5 15.2   
PTSD Treatment       1.06(2) .59 
 Cognitive processing therapy 12 63.2 8 57.1 20 60.6   
 Prolonged exposure therapy 6 31.6 6 42.9 12 36.4   
 Eye movement desensitization 
and reprocessing 
1 5.3 0 0.0 1 3.0   
Note. OEF/OIF = Operation Enduring Freedom, Operation Iraqi Freedom. 
 
Primary and Secondary Variables 
 
The primary outcomes of interest for this study included: PTSD symptoms 
(measured by the PCL-5), quality of life (measured by the QOLS), and valued living 
(measured by the VQ). The secondary outcomes of interest for this study included 
depression (measured by the PHQ-9), shame (measured by the ISS), and moral injury 
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(measured by MIES). See Appendix C for visual representation of data Last, processes of 
change measures for this study included cognitive defusion (measured by the BAFT) and 
psychological flexibility (measured by the AAQ-II). 
 
Summary of Outcome Variables by  
Completer Status  
To examine differences in primary outcomes at baseline between treatment 
completers and noncompleters, a series of independent samples t tests were conducted on 
all primary, secondary, and process measures at pretreatment. Table 6 provides the 
means, standard deviation, and p values for pretreatment measures for completers, 
noncompleters and the total sample. Results showed that completers and noncompleters  
 
Table 6 
 
Summary of Outcomes by Completers Versus Noncompleters 
 
 Completers 
(n = 19) 
────────── 
Dropout 
(n = 14) 
────────── 
Total  
(n = 33) 
────────── 
   
Variable Mean SD Mean SD Mean SD t df p 
PCL-5 45.69 16.20 44.23 14.45 45.10 15.26 -2.68 31 .79 
PTSD dx       -.025 31 .98 
PHQ-9 14.84 5.92 14.29 7.40 14.61 6.50 -2.40 31 .81 
WHO-5 9.32 4.95 9.93 3.50 9.60 4.34 .39 31 .70 
ISS 49.05 20.84 54.64 23.50 51.43 21.82 .72 31 .48 
QOLS 61.80 16.24 62.21 20.70 62.00 17.94 1.57 31 .10 
AAQ-II 32.05 10.20 31.86 10.62 31.97 10.21 -.05 31 .96 
VQ progress 15.79 5.63 15.21 5.90 15.67 5.74 -.13 31 90 
VQ obstruction  16.90 5.42 18.00 5.49 17.36 5.40 0.58 31 .57 
BAFT somatic concerns 19.10 7.85 20.8i6 6.6 19.84 7.28 0.68 31 .50 
BAFT negative evaluation 26.70 9.55 31.14 9.13 28.58 9.50 1.35 31 .19 
BAFT emotion regulation 24.60 7.65 27.30 6.50 25.73 7.20 1.07 31 .29 
Moral injury transgressions 17.86 9.31 16.40 6.71 17.23 8.22 -5.04 31 .62 
Moral injury betrayal  7.16 3.65 9.00 2.80 7.94 3.40 1.57 31 .13 
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did not significantly differ on primary and secondary variables of interest at pretreatment. 
As before, no adjustments were made to the data. 
 
Statistical Approach on Main Analysis  
To assess the effectiveness of an ACT intervention for veterans with PTSD/ 
subclinical PTSD, individual rates of positive response were calculated using three 
methods. Response rates were the percentage of veterans who could be classified as 
“responders” to treatment. Following guidelines presented by Loerinc et al. (2015) 
multiple modalities are best when determining clinically significant change (Loerinc et 
al., 2015). First, the degree of change from baseline was calculated by simply taking the 
difference between pre- and posttreatment PCL-5 scores. Following recommendations by 
the National Center for PTSD, to determine a clinical change on the PCL for the DSM-
IV, a 5-point change was used as a minimum score to determine “response to treatment” 
and a 10-point change was used to determine if change was “clinically meaningful.” 
While change scores have yet to be determined for the PCL-5, research suggests that they 
will be in the similar range to the PCL for DSM-IV (e.g., Blevins, Weathers, Davis, 
Witte, & Domino, 2015; Bovin et al. 2015; Wortmann et al., 2016).  
Next, the reliable change index (RCI; Jacobson & Truax, 1991) was calculated for 
the PCL-5. The RCI is a more stringent method for determining response to treatment. 
The RCI aims to calculate the standard error of the difference between pretreatment and 
posttreatment scores, identifying the spread of the distribution of change scores if no real 
change had occurred. Thus, an RCI offers a measurement of change in standardized units, 
such that an RCI >1.96 would reflect statistically significant change posttreatment.  
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Third, we utilized a clinical cut-off score, to identify the veterans who decreased 
below the clinical range on the PCL-5. The National Center for PTSD suggests a cut-
point of 33 until further psychometric evaluation has been conducted on the PCL-5 
(Weathers et al., 2013).  
To examine changes on the main outcomes measures a series of one-way repeated 
measures analysis of variance (ANOVAs) were conducted. One-way repeated measures 
ANOVAs (within-subject ANOVAs) were used to determine whether there was a 
statistically significant difference between pretreatment, posttreatment, and follow-up 
means on the main outcomes of interest. 
 
Primary Outcome Variables  
 
Research Question 1: (a) Is ACT an effective treatment for veterans with PTSD or 
subclinical PTSD?  
Of the 19 individuals who completed treatment, seventeen completed the PCL-5, 
in its’ entirety. Results showed 64.7% of the sample (n = 11) showed a response to 
treatment, utilizing the 5-point cut-off, while 35.3% did not (n = 6). Utilizing the 10-point 
cut-off to determine clinically meaningful change, results showed that 35.3% of the 
sample (n = 6) showed a clinically meaningful change, while 64.7% did not (n = 11). 
Lastly, results showed that 23.5% of the sample (n = 4) showed statistically significant 
change, utilizing the RCI > 1.96 cutoff. Because the purpose of this study was 
exploratory, along with the small sample size, the 5-point change score, indicating a 
significant response to treatment was used in the subsequent analyses.  
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Research Question 1b. Does ACT positively impact PTSD symptom severity, 
quality of life, valued living, depression, shame, and moral injury? 
One-way repeated measures ANOVAs were implemented to determine if primary 
outcomes of interest progressed in the predicted direction from pretreatment to 
posttreatment to follow-up. Table 7 presents means and stand deviations for all primary 
and secondary outcome measures. 
A one-way repeated measures ANOVA was conducted to compare the effect of 
an ACT intervention on PTSD symptoms (PCL-5) from pretreatment to posttreatment to 
follow-up. As predicted, results revealed a significant effect of time on PTSD symptoms, 
F(2, 64) = 3.40, p = .04, partial η2 = .096. Post hoc test of multiple comparisons, using 
 
Table 7 
 
Outcome Means and Standard Deviations from Pretreatment, Posttreatment, and Follow-
Up 
  
 Pretreatment  
(n = 33) 
Posttreatment  
(n = 33) 
Follow-up  
(n = 33) 
Variable M SD M SD M SD 
Primary outcomes       
 PTSD symptoms (PCL-5)  45.07 15.27 40.52 14.02 40.97 18.91 
 Quality of life (QOLS)  61.97 16.10 64.60 13.75 60.69 14.76 
Secondary outcomes       
 Depression (PHQ-9) 13.03 5.82 11.38 5.24 14.67 8.33 
 Shame (ISS) 51.42 21.82 52.79 22.23 54.10 23.28 
 Moral injury (MIES)       
  Transgression 17.23 6.27 14.86 6.77 19.77 6.63 
  Betrayal  7.94 2.80 8.10 2.50 9.33 4.10 
 Well-Being (WHO-5) 9.60 4.34 13.07 4.60 8.74 5.01 
Note. PCL-5 = Posttraumatic Stress; QOLS = Quality of Life Scale; PHQ-9 = Patient Health Questionnaire; 
ISS = Internalized Shame Scale; MIES = Moral Injury Events Scale; WHO-5 = World Health Organization 
Well-Being Index. 
53 
 
the Sidak corrections, indicated that PTSD symptoms significantly decreased from 
pretreatment (M = 45.07, SD = 15.27) to posttreatment (M = 40.52, SD = 14.02; p = 
.022), however the effect of time on PTSD symptoms did not maintain from pretreatment 
to follow-up (p = .15). A Cohen’s d effect size was calculated comparing pretreatment to 
posttreatment PTSD symptom severity scores. We followed the formula for a Cohen’s d 
effect size by subtracting the mean scores at posttreatment from the mean scores 
pretreatment divided by the standard deviation. Results showed a small to moderate 
effect size, Cohen’s d = 0.31. Taken together, these results suggest that an ACT 
intervention was effective in reducing PTSD symptoms pre-to post- treatment; however, 
these gains did not maintain to follow-up.  
A one-way within subjects ANOVA was conducted to compare the effect of an 
ACT intervention on quality of life (QOLS) from pretreatment to posttreatment to follow-
up. Results revealed a significant effect of time on quality of life, F(2, 64) = 4.01, p = 
.023, partial η2 = .11. However, post hoc test of multiple comparisons, using the Sidak 
corrections, indicated that quality of life did not significantly improve from pretreatment 
(M = 61.97.07, SD = 16.10) to posttreatment (M = 64.60, SD = 13.75) (p = .20), while the 
difference between quality of life from pretreatment to follow-up was significant (p = 
.005). Contrary to predictions, these results suggest that an ACT intervention did not have 
an overall positive effect on a measure of quality of life from pre- to posttreatment and 
follow-up.  
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Secondary Outcome Variables 
 
 
To determine the effectiveness of ACT on secondary outcome variables of 
interest similar ANOVA procedures were conducted; one-way repeated measures 
ANOVAs were implemented to determine if general wellbeing (WHO-5), depression 
(PHQ-9), moral injury (MIES) and shame (ISS) significantly changed over the course of 
treatment and follow-up. Means and standard deviations were presented in Table 7. 
For general wellbeing (WHO-5), results on a one-way ANOVA yielded 
significant effects by time, F(1.64, 51.97) = 23.34, p < .001, partial η2 = .42. The 
Mauchly’s test of sphericity indicated that the assumptions of sphericity had been 
violated, X2 (2) = 10.20, p = .017, therefore degrees of freedom were corrected by 
reporting the Greenhouse-Geisser estimates for the WHO-5. Post hoc test of multiple 
comparisons, using the Sidak corrections, indicated that general well-being significantly 
increased from pretreatment (M = 9.60, SD = 4.34) to posttreatment (M = 13.07, SD = 
4.60) (p < .001), however pretreatment scores did not significantly differ from follow-up 
scores (p = .67). Results showed a large effect size from pretreatment to posttreatment, 
Cohen’s d = 0.77. General wellbeing decreased from posttreatment (M =13.07, SD = 
4.60) to follow-up (M = 8.74, SD = 5.01). As predicted, wellbeing significantly improved 
pre- to posttreatment, however gains were not maintained at follow-up.  
For shame (ISS), results on a one-way repeated measures ANOVA yielded no 
significant effect by time, F(1.60, 50) = .71, p = .46, partial η2 = .022. Of note, the 
Mauchly’s test of sphericity indicated that the assumptions of sphericity had been 
violated, X2 (2) = 8.16, p = .006 therefore degrees of freedom were corrected by reporting 
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the Greenhouse-Geisser estimates for the ISS.  
For depression (PHQ-9), results on a one-way repeated measures ANOVA 
yielded significant effects by time F(2, 64) = .731, p = .003, partial η2 = .188. The 
Mauchly’s test indicated that the assumptions of sphericity had been violated, X2 (2) = 
10.27, p = .006 therefore degrees of freedom were corrected by reporting the 
Greenhouse-Geisser estimates for the PHQ-9. Post hoc test of multiple comparisons, 
using the Sidak corrections, indicated that depression significantly decreased from 
pretreatment (M = 13.03, SD = 5.82) to posttreatment (M = 11.38, SD = 5.24, p = .024), 
however pretreatment scores did not show a significant difference from follow-up scores 
(p = .25). Results showed a small to medium effect size from pre- to posttreatment, 
Cohen’s d = 0.30. Inconsistent with predictions, depression appeared to (significantly) 
increase from posttreatment to follow-up (p = .006).  
For moral injury events by perceived transgressions (MIES), a one-way ANOVA 
yielded significant differences by time, F(2,64) = 20.40, p < .001, partial η2 = .40. Post 
hoc test of multiple comparisons, using the Sidak corrections, indicated that perceived 
transgressions of moral injury, significantly decreased from pretreatment (M = 17.23, SD 
= 6.27) to posttreatment (M = 14.86, SD = 6.77, p = .033). Contrary to predictions, scores 
significantly increased from pretreatment (M = 17.23, SD = 6.27) to follow-up (M = 
19.77, SD = 6.63, p = .006). Taken together, the number of perceived moral injury events 
by transgressions significantly decreased pre-to posttreatment; however, contrary to 
predictions, the number of perceived moral injury events by transgression increased from 
pretreatment to follow-up.  
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For moral injury events by perceived betrayals (MIES), a one-way ANOVA 
yielded significant differences by time, F(2,64) = 7.08, p =.002, partial η2 = .18. Post hoc 
test of multiple comparisons, using the Sidak corrections, indicated that the number of 
reported moral injury events by perceived betrayals, did not significantly decrease from 
pretreatment treatment (M = 7.94, SD = 2.76) to posttreatment (M = 8.10, SD = 2.50, p 
=.94). Contrary to predictions, the number of reported moral injury events by perceived 
betrayals significantly increased from pretreatment (M = 7.94, SD = 2.76) to follow-up 
(M = 9.33, SD = 4.10, p = .006). Taken together, the number of perceived betrayals on 
the moral injury events scale did not significantly improve pre- to posttreatment and 
follow-up.  
 
Process of Change Measures 
  
 
With respect to process measures, participants completed measures of 
psychological flexibility and valued living at pretreatment, mid-point 1 (session three), 
mid-point 2 (session six), posttreatment and follow-up. One-way repeated measures 
ANOVAs were implemented to determine if process of change measures (AAQ-II, VQ, 
BAFT) progressed in the predicted direction from pretreatment to posttreatment to 
follow-up. Table 8 includes the means and stand deviations.  
Results showed a nearly significant effect of time on psychological flexibility F(2, 
64) = 3.08, p = .053, partial η2 = .088. Post hoc test of multiple comparisons, using the 
Sidak corrections, indicated that changes in psychological flexibility from pretreatment to 
posttreatment were nonsignificant (p = .663) and were nonsignificant from pretreatment  
57 
 
Table 8 
 
Process Measures Means and Standard Deviations from Pretreatment, Posttreatment, 
and Follow-Up 
  
 Pretreatment 
(n = 33) 
───────── 
Session 3 
(n = 33) 
───────── 
Session 6 
(n = 33) 
───────── 
Posttreatment 
(n = 33) 
───────── 
Follow- Up 
(n = 33) 
───────── 
Variable M SD M SD M SD M SD M SD 
Psychological 
Flexibility  
(AAQ-II) 
31.97 10.21 31.46 8.75 31.72 8.10 30.81 9.30 33.80 8.10 
Defusion (BAFT)   - - - -     
Negative 
evaluation 
28.33 9.10 - - - - 27.81 7.53 30.20 5.80 
Somatic concerns 19.84 7.30 - - - - 16.24 6.30 20.72 6.22 
Emotion 
regulation  
25.72 7.20 - - - - 22.41 6.40 24.62 5.74 
Valued living 
(VQ)  
          
Obstruction 17.36 5.40 17.50 6.22 18.03 4.82 14.42 6.20 16.10 6.10 
Progress 15.70 5.74 17.33 5.43 18.21 5.50 16.91 2.85 19.90 4.00 
Note. AAQ-II= Acceptance and Action Questionnaire, BAFT = Believability of Anxious Thoughts and Feelings, VQ= 
Valuing Questionnaire. 
 
 
to follow-up (p = .46). Of note, results showed that psychological flexibility significantly 
decreased posttreatment to follow-up (p = .045).  
On a one-way repeated measures ANOVA, results showed a trend towards a 
significant effect of time on obstruction to Valued Living, F(2, 64) = 2.96, p = .06, partial 
η2 = .085. Post hoc test of multiple comparisons, using the Sidak corrections, indicated 
that obstruction in valued living significantly decreased pretreatment (M = 17.36, SD = 
5.39) to posttreatment (M = 14.23, SD = 6.20, p = .018). However, results showed that 
obstruction to valued living did not significantly improve from pretreatment to follow-up 
(p = .70). As predicted, obstruction to Valued Living trended towards a significant 
decrease from pre- to posttreatment; however, obstruction to valued living did not 
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significantly change from pretreatment to follow-up.  
Results showed a significant effect of time on progress in Valued Living F(1.65, 
52.80) = 9.05, p = .001, partial η2 = .220. The Mauchly’s test of sphericity indicated that 
the assumptions of sphericity had been violated, X2 (2) = 7.40, p = .025, therefore 
Greenhouse-Geisser estimates were reported for progress in Valued Living. Post hoc test 
of multiple comparisons, using the Sidak corrections, indicated that progress in Valued 
Living did not significantly improve from pretreatment (M = 15.70, SD = 5.74) to 
posttreatment (M = 16.91, SD = 2.85, p = .64), however pretreatment scores (M = 15.70, 
SD = 5.74) significantly differed from follow-up scores (M = 19.90, SD = 4.00, p = .002). 
As predicted, progress in Valued Living significantly improved from pretreatment to 
follow-up.  
Results showed a significant effect of time on somatic concerns on the BAFT, 
F(2, 64) = 12.11, p < .001, partial η2 = .275. Post hoc test of multiple comparisons, using 
the Sidak corrections, indicated that somatic concerns on the BAFT significantly 
decreased from pretreatment (M = 19.84, SD = 7.30) to posttreatment (M = 16.24, SD = 
6.30, p = .002). However, results showed that somatic concerns on the BAFT did not 
significantly improve from pretreatment to follow-up (p = .73). As predicted, fusion with 
anxious thoughts and feelings related to somatic concerns decreased pre- to 
posttreatment, however improvements did not maintain at follow-up.  
Results showed a significant effect of time on emotion regulation on the BAFT, 
F(2, 64) = 6.25, p = .003, partial η2 = .163. Post hoc test of multiple comparisons, using 
the Sidak corrections, indicated that emotion regulation on the BAFT significantly 
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decreased from pretreatment (M = 25.72, SD = 7.20) to posttreatment (M = 22.41, SD = 
6.40, p = .017). However, results showed that emotion regulation on the BAFT did not 
significantly improve pretreatment to follow-up (p = .46). As predicted, fusion with 
anxious thoughts and feelings related to emotion regulation improved pretreatment to 
posttreatment, however improvements did not maintain at follow-up.  
Results showed a significant effect of time on negative evaluation on the BAFT, 
F(1.62, 52.54) = 4.40, p = .024, partial η2 = .120. The Mauchly’s test of sphericity 
indicated that the assumptions of sphericity had been violated, X2 (2) = 7.63 p = .022, thus 
Greenhouse-Geisser estimates were reported. Post hoc test of multiple comparisons, 
using the Sidak corrections, indicated that negative evaluation on the BAFT, did not 
significantly improve from pretreatment to posttreatment (p = .90), nor from pretreatment 
to follow-up (p = .22). However, results showed that negative evaluation on the BAFT 
significantly increased from posttreatment to follow-up (p = .005). Contrary to 
predictions, fusion with anxious thoughts and feelings related to negative evaluations did 
not improve over the course of treatment and appeared to worsen from posttreatment to 
follow-up. 
 
Secondary Outcomes 
 
Research Question 2a. Do pretreatment levels depression, shame, moral injury 
and well-being predict response to treatment?  
Research Question 2b. Do pretreatment levels of psychological inflexibility and 
cognitive fusion predict response to treatment?  
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Prior to regression analyses, we examined the relationship between depression, 
moral injury, shame, wellbeing and the primary outcome variables of interest including 
PTSD diagnostic status, PTSD symptoms, valued living, and quality of life. Pearson R 
correlations were used to determine the association between variables. Table 9 presents 
correlations between pretreatment measures and primary outcome variables.  
As shown in Table 9, veterans with a PTSD diagnosis showed a strong positive 
correlation with PTSD symptoms (PCL-5), r = .66, p < .01 and a strong positive 
correlation with shame (ISS), r = .37, p < .05. PTSD diagnostic status showed a negative 
relationship with quality of life (QOL) r = -.45 p < .01 and progress in valued living r = -
.36, p < .01. As expected, PTSD symptoms at pretreatment (PCL-5) showed a strong 
negative correlation with quality of life (QOL), r = -.71, p < .01; progress in valued living 
(VQ-progress), r = -.54, p < .01 and overall well-being (WHO-5), r = -.64, p < .01. 
Results showed a strong positive correlation between PTSD symptoms (PCL-5) and 
obstruction in valued living (VQ-obstruction) r = .71, p < .01, shame (ISS), r = .58, p < 
.01 and depression (PHQ-9) r = .72 p < .01. Furthermore, findings show strong negative 
correlations between quality of life (QOLS) and obstruction to valued living (VQ-
obstruction), r = -.57, p < .01, shame (ISS) r = -.60, p < .01, and depression (PHQ-9), r 
= -.77, p < .01. There were strong positive correlations between quality of life (QOL) and 
progress in valued living (VQ-progress), r = .64, p < .01 and overall well-being (WHO-
5), r = .722, p < .01. As expected, results showed a strong negative correlation between 
obstruction in valued living (VQ-obstruction) and progress in valued living (VQ-
progress), r = -.36, p < .05 and obstruction in valued living (VQ-obstruction) and overall  
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Table 9 
Bivariate Correlations Among Predictor and Primary Outcome Variables Pretreatment 
Variables 1 2 3 4 5 6 7 8 9 10 
1.PCL-5 dx -          
2.PCL-5  .66** -         
3.QOLS  -.45** -.71** -        
4.VQ-obstruction  .17 .71** -.57** -       
5. VQ-progress  -.36* -.54** .64** -.36* -      
6. ISS  .37* .58** -.60** .56** -.66** -     
7 PHQ-9  .44* .72** -.77** .55** -.72** .62** -    
8. MIES-betrayal  -.30 -.15 .06 .04 .18 -.26 -.29 -   
9. MIES-transgression  -.28 -.26 .18 -.12 .28 -.33 -.21 .25 -  
10. WHO-5 -.24 -.64** .72** -.67** .42* -.29 -.73** .04 .07 - 
Note. PCL-5 dx = PTSD diagnostic status; PCL-5 = PTSD checklist; QOLS = Quality of Life Scale; VQ-
obstruction/progress = Valuing Questionnaire; ISS = Internalized Shame Scale; PHQ-9 = Patient-Health 
Questionnaire; MIES = Moral Injury Event Scale; WHO-5 = World Health Organization Well Being Index. 
 
* p < .05. 
**p < .01. 
 
wellbeing (WHO-5), r = -.67, p < .01. Results showed that obstruction in valued living 
(VQ-obstruction) had a strong positive correlation with shame (ISS) r = .56, p < .01 and 
depression (PHQ-9), r = .55, p < .01. Additionally, progress in valued living (VQ-
progress) showed a strong negative correlation with shame (ISS), r = -.66, p < .01 and 
depression (PHQ-9), r = -.72, p < .01 and a positive correlation with well-being (WHO-
5), r = .42, p < .05. Shame (ISS) and depression (PHQ-9) showed a strong positive 
correlation r = .622, p < .01. Of note, moral injury showed no significant correlations 
with any pretreatment measures.  
2a. Do pretreatment levels depression, shame, moral injury, well-being predict 
response to treatment?  
Binomial logistic regression analyses were conducted in SPSS version 23.0, to 
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determine if pretreatment symptoms significantly predicted response to treatment, as 
measured by a 5-point change on the PCL-5. Specifically, we aimed to predict the 
probability that a veteran showed a response to treatment based on pretreatment symptom 
scores.  
 In order to determine covariates for the model, a series of regression analyses 
were conducted with blocks of demographic variables (e.g., age, educational, marital 
status, race/ethnicity, religion, PTSD dx) and military characteristics (e.g., years in 
service, branch, era, number of deployments, previous PTSD treatment). Results found 
branch of military service to be a significant predictor of PTSD change from pretreatment 
to posttreatment; however, once placed in the model with other variables branch of 
military service was nonsignificant and, therefore, excluded from the model. 
Furthermore, all other demographic variables were nonsignificant and were excluded 
from the model.  
To assure that all appropriate assumptions were met for the logistic regression 
model several procedures were conducted. First, to assess for linearity between the 
continuous variables and the logit of the dependent variable, Box-Tidwell (1962) 
procedures were followed. Results showed that each of the predictor variables were 
linearly related to the logit of the dependent variable (PCL-5 change). Second, to assess 
for multicollinearity, Tolerance/VIF statistics were examined. VIF scores of ten or 
greater were used to indicate serious multicollinearity (Cohen, Cohen, West, & Aiken, 
2013). Some mulitcollinearity was detected between the PHQ-9 and the MIES 
transgression (VIF = 3.71) and the PHQ-9 and MIES betrayal (VIF = 3.6). Third, to 
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assess for significant outliers, residuals were assessed. Results showed that there was one 
studentized residual on the depression variable (PHQ-9) = -3.04, which remained in the 
analyses.  
Next, a series of simple logistic regressions were conducted to assess the whether 
pretreatment depression, shame, moral injury and well-being predicted the likelihood that 
a veteran showed a positive response to treatment. All results are presented in Table 10. 
Contrary to predictions, results showed that pretreatment levels of depression, shame, 
well-being, and moral injury due to perceived betrayals did not significantly predict a 
response to treatment as measured by a 5-point change in PTSD symptoms pre- to 
posttreatment. Results showed that pretreatment levels of moral injury by perceived 
transgressions was significant in predicting a response to treatment (5-point change on 
 
Table 10 
Logistic Regression Predicting Likelihood in PTSD Treatment Response Based on 
Pretreatment Symptoms 
 
Variables B 
 
SE Wald df 
 
p 
Odds 
ratio 
95% CI 
Lower 
95% CI 
Lower 
PHQ-9 .11 .078 2.08 1 .15 1.12 .96 1.30 
ISS .02 .018 1.11 1 .29 1.02 .98 1.06 
WHO-5 -.11 .092 1.53 1 .22 .89 .75 1.07 
MIES-B -.11 .155 0.90 1 .34 .90 .72 1.12 
MIES-T -.11 .053 4.26 1 .04 .90 .81 .99 
AAQ-II .06 .039 2.11 1 .15 1.06 .98 1.14 
BAFT er .05 .090 0.35 1 .56 1.05 .88 1.26 
BAFT sm .12 0.11 1.16 1 .28 1.13 .91 1.4 
BAFT ne -.09 0.10 0.85 1 .36 .91 .75 1.11 
Note. PHQ-9 = Patient-Health Questionnaire; ISS = Internalized Shame Scale; WHO-5 = World Health 
Organization Well Being Index, MIES = Moral Injury Event Scale; MIES-B = Moral Injury Events Scale 
Betrayals; MIES-T = Moral Injury Events Scale Transgressions; AAQ-II = Acceptance and Action 
Questionnaire, BAFT = Believability of Anxious Thoughts and Feelings, er = emotion regulation, sm = 
somatic concerns, ne = negative evaluation.  
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the PCL-5) from pre- to posttreatment. The logistic regression model was statistically 
significant X2 (1) = 4.96, p = .026 and correctly classified 69.7% of the participants. In 
this model, moral injury measured by perceived transgressions explained 19.4% 
(Nagelkerke R square) of the variance. Furthermore, increasing the number of reported 
moral injuries by perceived transgressions was associated with a reduction in the 
likelihood of showing a statistically significant response to treatment. Specifically, a one-
unit change in moral injury by perceived transgressions decreased the log odds by .88.  
2b. Do pretreatment levels of psychological inflexibility and cognitive fusion 
predict response to treatment?  
Additional logistic regressions were conducted to predict response to treatment 
based on pretreatment levels of psychological inflexibility (AAQ-II) and cognitive fusion  
(BAFT). Again tests of assumptions were conducted to assess for linearity, 
multicollinearity, and significant outliers. A bonferroni correction was made for all the 
independent variables and the interaction terms, which suggested that p < .0065 
represented statistical significance (Tabachnick & Fidell, 2007). Tests of assumptions 
showed that all independent variables were found to be linearly related the logit of the 
dependent variable. Of note, moderate mulitcollinearity existed between the AAQ-II and 
the BAFT somatic concerns (VIF = 3.86) and the AAQ-II and BAFT negative effect 
(VIF = 5.43). As one might expect, multicollinearity existed between the BAFT 
subscales; specifically, the BAFT somatic concerns and BAFT negative evaluation (VIF 
= 4.23) and BAFT emotion regulation and BAFT somatic concerns (VIF = 3.89) and 
BAFT somatic concerns and BAFT negative evaluation (VIF = 5.22). Finally, test of 
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assumptions revealed one studentized residual on the BAFT variable -2.5, which 
remained in the analyses.  
Results showed that pretreatment levels of psychological inflexibility (AAQ-II) 
did not significantly predict a response to treatment as measured by a 5-point change in 
PTSD symptoms pretreatment to posttreatment. Further, results from the logistic 
regression found that cognitive fusion at pretreatment did not significantly predict a 
response to treatment. Contrary to predictions, greater psychological inflexibility and 
higher cognitive fusion at pretreatment was not predictive of response to treatment.  
Research Question 3: Do changes in psychological flexibility (AAQ-II) and 
Valued Living (VQ) predict PTSD symptom severity posttreatment? 
In order to assess whether changes in treatment processes predicted changes in 
outcomes, above baseline functioning, bivariate correlation analyses were conducted. 
First, change scores were calculated (AAQ pretreatment - AAQ session 6) and (VQ 
pretreatment- VQ session 6). Next, a bivariate correlation was conducted to assess the 
relationship between changes in psychological flexibility (AAQ change) and PTSD 
posttreatment (PCL-5). Preliminary analyses showed the relationship to be monotonic, 
which was assessed through visual inspection of a scatterplot of the two variables. 
Results showed that there was a weak positive correlation between changes in 
psychological flexibility and PTSD symptom severity at posttreatment, rs (31) = .284, p = 
0.11. Contrary to predictions, change in psychological flexibility over the course of 
treatment was not significantly associated with PTSD posttreatment.  
Another Spearman’s rank-order correlation was conducted to assess the 
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relationship between changes in valued living and PTSD symptoms posttreatment. Again, 
preliminary analyses showed the relationship to be monotonic, which was assessed 
through visual inspection of a scatterplot of the two variables. Results showed that there 
was a weak negative correlation between changes in progress towards Valued Living and 
PTSD symptom severity at posttreatment, rs (31) = -.23, p = 0.19. Contrary to 
predictions, a change in valued living over the course of treatment was not significantly 
associated with PTSD symptoms posttreatment. Results showed that there was a weak 
positive correlation between changes in obstruction to Valued Living subscales and 
PTSD symptom severity posttreatment, rs (31) = .11, p = 0.55.  
Research Question 4: How acceptable is ACT as an intervention for veterans 
diagnosed with PTSD? 
To assess treatment acceptability scores on the TEI-SF were evaluated from both 
posttreatment and follow-up assessments. As predicted, results showed that a majority of 
veterans who completed treatment 97% (n = 18), found the ACT intervention to be highly 
acceptable (a score > 21). Scores range from 0 to 35 with higher scores indicating greater 
acceptability (M = 28.26, SD = 3.20) and follow-up (M = 28.00, SD = 3.91).  
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CHAPTER V 
 
DISCUSSION  
 
 
Primary Outcomes 
 
 
The present study examined the effectiveness of an ACT intervention for veterans 
with PTSD and subclinical PTSD who had previously completed a gold standard 
treatment for PTSD (n = 33). An 8-week closed group design was used, which 
implemented a protocol focused on increasing valued living and decreasing experiential 
avoidance. The main outcomes of interest were changes in PTSD symptoms, valued 
living, and quality of life from pre- to posttreatment, and again at 1-month follow-up.  
Results showed that 64.7% of veterans showed a favorable response to treatment 
as measured by a 5-point change in PTSD symptoms. Further analyses found that 35.3% 
of veterans showed a clinically meaningful change (10-point change on PCL-5) over the 
course of treatment and 25.3% of veterans showed a reliable change utilizing the reliable 
change index. Results suggest that a majority of the veterans—with PTSD or 
subthreshold PTSD- experienced a positive response to treatment. Perhaps, the lack of 
clinically meaningful change among some of the study sample can be associated with the 
chronic nature of their PTSD. Additionally, the lack of reliable change for many on the 
major outcome of interest (PCL-5) may be attributed to the stringent nature of the reliable 
change index (Benotsch et al., 2000; Loerinc et al., 2015).  
Overall, findings from this study on primary outcomes of interest were mixed. 
Primary outcomes included PTSD symptoms, quality of life, and valued living. As 
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hypothesized, results showed that PTSD symptoms (PCL-5) significantly decreased from 
pre- to posttreatment, although no significant difference was found at the one-month 
follow-up assessment. These findings are consistent with previous literature suggesting 
that up to two-thirds of veterans completing the gold standard treatments for PTSD, retain 
their diagnosis posttreatment, mean scores remain at or above the clinical cutoff, and full 
remission is rare (Steenkamp et al., 2015).  
The VQ consists of subscales measuring progress and obstructions towards 
valued living. In line with predictions, veterans showed a significant improvement in 
progress towards valued living from pre- to follow-up. Results showed that veterans 
showed a trend towards a significant reduction in obstructions to valued living from pre- 
to posttreatment. However, obstructions towards valued living did not improve 
pretreatment to follow-up. It is possible that weekly check-ins regarding behavioral 
commitments, highlighted a veteran’s progress and barriers towards valued living. 
Perhaps, this weekly exercise enhanced a veteran’s awareness of moving towards a 
valued life, while simultaneously increasing a veteran’s sensitivity to barriers or 
obstructions that impede progress towards valued living.  
The QOLS broadly measures life satisfaction at the time of assessment. Contrary 
to predictions, quality of life did not significantly increase from pre- to posttreatment. 
Furthermore, results showed a significant decrease in quality of life from pretreatment to 
follow-up. One possible explanation is that improvement in quality of life may require 
more than 8 to 12 weeks to observe in veterans with chronic PTSD/subthreshold PTSD. 
Another possibility is that veterans with PTSD may consider all life experiences 
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including military deployments and trauma exposure, when responding to questions on 
overall life satisfaction.  
Results on secondary outcome variables of interest provided additional 
information on the effectiveness of an ACT group for veterans with PTSD/subthreshold 
PTSD. The secondary outcome variables of interest were measures of depression (PHQ-
9), moral injury (MIES), shame (ISS), and general wellbeing (WHO-5). Consistent with 
predictions, veterans showed significant improvements from pre- to posttreatment on 
overall wellbeing and depression; however, gains did not maintain at follow-up. Research 
suggests that active participation in a group intervention may provide social support and 
eliminate avoidant behaviors (e.g., Sripada et al., 2016). Perhaps, weekly group 
attendance improved a veteran’s social support network, decreased avoidant behaviors, 
and ultimately alleviated depressive symptoms. However, it is also possible that veterans 
experienced the opposite upon group termination. As a result, veterans may have returned 
to avoidant behavior patterns that once contributed to baseline depression and poor 
general wellbeing.  
Contrary to predictions, results showed no significant difference in shame 
symptoms (ISS) from pre- to posttreatment and follow-up. One explanation is that the 
content and experiential exercises of the intervention did not accurately target the 
construct of shame. Research suggests that treatment of shame is most effective when the 
construct is targeted directly (J. B. Luoma, Kohlenberg, Hayes, Bunting, & Rye, 2008).  
The moral injury event scale measured the number of moral injury events (MIEs) 
experienced by a veteran. The MIES consists of two subscales, one that measures moral 
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injurious events that are associated with perceived betrayals and one that measures moral 
injurious events that are associated with perceived transgressions. Consistent with our 
prediction, the number of perceived transgressions significantly decreased from pre- to 
posttreatment. However, results showed that perceived transgressions increased from 
pretreatment to follow-up. Interestingly the number of perceived betrayals did not 
significantly decrease over the course of treatment. One possible explanation is that the 
MIES assesses the number of events experienced rather than assessing the quality or 
content of the events. From a theoretical perspective, one might expect ACT to improve 
acceptance of MIEs, but not necessarily alter the number of reported MIEs.  
 Additionally, we examined process of change measures including the AAQ-II and 
the BAFT. Results showed that psychological flexibility did not significantly improve 
over the course of treatment, and decreased from posttreatment to follow-up. One 
explanation is that an eight-week intervention was insufficient at producing lasting 
change on the measure of psychological flexibility. Yet, another explanation is that the 
AAQ-II has had some difficulty detecting change in clinical outcome research, as this 
version of the measure uses broad language that may not be specific enough to capture 
psychological flexibility related to posttraumatic stress (e.g., J. Luoma, Drake, 
Kohlenberg, & Hayes, 2011).  
The BAFT consists of three subscales, measuring cognitive fusion with somatic 
concerns, emotion regulation, and negative evaluation. Consistent with predictions, 
cognitive fusion related to somatic concerns and emotion regulation significantly 
decreased over the course of treatment, however gains were not maintained at follow-up. 
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Of note, cognitive fusion related to negative evaluation did not significantly improve and 
appeared to increase from posttreatment to follow-up. Perhaps, the treatment protocol 
included experiential exercises that emphasized an acceptance of internal experiences 
associated with somatic and emotional concerns more so than negative evaluation. 
However, this is unlikely given that two sessions were devoted to cognitive defusion 
exercises. 
Taken together, these results suggest that an eight-week ACT group intervention 
was effective at reducing PTSD symptoms, increasing progress towards valued living, 
decreasing depression and increasing wellbeing. Specifically, this treatment produced 
small to moderate effect sizes, good clinical effectiveness pre- to posttreatment however, 
treatment gains at follow-up were poor.  
 
Secondary Outcomes 
 
 
 In addition to the primary and secondary analyses of interest, we were interested 
in whether pretreatment levels of depression, shame, moral injury and wellbeing would 
predict response to treatment. Contrary to predictions, results showed that levels of 
depression, shame, and wellbeing at pretreatment did not significantly predict a response 
to treatment. These findings are inconsistent with a previous research study, which found 
moderate to severe depression at pretreatment to predict a greater reduction in symptoms 
posttreatment. However, the same study showed that individuals with higher symptom 
severity at baseline continued to experience significant symptoms posttreatment 
(Felleman, Stewart, Simpson, Heppner, & Kearney, 2016). An alternative explanation for 
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null findings could be the small sample size used in the logistic regression analyses. 
Some researchers suggest a minimum of 50 cases in order to conduct logistic regression, 
while others suggesting a bare minimum of 15 cases (Peng, Lee, & Ingersoll, 2002). 
Interestingly, results showed that the number of moral injury event (MIEs) due to 
perceived transgressions was a significant predictor for response to treatment. 
Specifically, the greater number of reported MIEs by transgression- the less likely a 
veteran would show a response to treatment. Perhaps, the number of MIEs experienced 
by a veteran is a maintaining factor for chronic PTSD. These findings are consistent with 
a recent study showing that veterans with refractory PTSD are more likely to recall MIEs 
that are internal rather than external. Furthermore, veterans in the study often expressed 
guilt and shame associated with actions they performed or participated in during 
deployment (Currier, McCormick, et al., 2015). Of note, moral injury by perceived 
betrayals was not a significant predictor of response to treatment. It is possible that a 
sense of betrayal by a leader is not a maintaining factor for PTSD. However, malpractice 
or betrayal from leadership is a vastly under-researched topic in the literature (Currier, 
McCormick, et al., 2015)  
Additional analyses examined whether pretreatment levels of psychological 
flexibility and cognitive fusion predicted a response to treatment. Contrary to predictions, 
neither pretreatment levels of psychological flexibility/experiential avoidance nor 
cognitive fusion predicted response to treatment. These findings are surprising 
considering the abundance of research that suggests greater experiential avoidance and 
cognitive fusion are related to posttraumatic stress symptoms (e.g., Benotsch et al., 2000; 
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Plumb et al., 2004; Tull et al., 2004). 
 
Process of Change 
 
 To examine whether ACT theorized process of change measures were associated 
with posttreatment symptom severity. To do so, change scores were calculated between 
pretreatment psychological flexibility ratings (AAQ-II) and session six psychological 
flexibility ratings (AAQ-II). Change scores were also calculated between pretreatment 
ratings of valued living (VQ) and session six ratings of valued living (VQ). Results 
showed that changes in psychological flexibility over the course of treatment 
(pretreatment AAQ-II scores—session six AAQ-II scores) were not significantly 
associated with PTSD symptom severity at posttreatment. These findings are surprising, 
given that the AAQ-II is a measure of psychological flexibility, the purported mechanism 
of change in ACT (Hayes et al., 2006). Perhaps, a change score over the course of six 
weeks was an insufficient amount of time to shift the broader construct of psychological 
flexibility. Further, contrary to predictions, results showed that changes in progress 
towards valued living and obstruction towards valued living, were not significantly 
associated with PTSD symptom severity posttreatment. It is possible that progress 
towards valued living, occurred regardless of the presence of PTSD symptoms, which 
may be expected from an ACT treatment model. An alternative explanation is that the 
VQ functions better as an outcome measure, rather than a process measure.  
 
Summary of Acceptability Outcomes  
 In addition to our primary outcomes, we were interested in whether or not ACT 
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would be an acceptable treatment for veterans with PTSD. As predicted, veterans who 
attended the group found it to be highly acceptable. It is important to note that a notable 
number of veterans did not fully complete the 8-week intervention. It is possible that drop 
out provides information regarding the acceptability of the treatment. Veterans may have 
found the group less acceptable or inconsistent with their expectations for treatment, 
ultimately resulting in dropout. Future studies may consider providing a more thorough 
explanation of the treatment prior to the initial session. It may also be important to 
explain to group participants that ACT utilizes experiential exercises and encourages 
active group participation, which may not be an appealing treatment approach for 
veterans with refractory PTSD.  
 
Empirical Implications 
 
 
Results from this study provide empirical support for ACT as a second-line 
intervention for PTSD. While data is limited, four case studies and one multiple baseline 
study found ACT to be an effective treatment for PTSD and comorbid disorders (Batten 
& Hayes, 2005; Burrows, 2013; Orsillo & Batten, 2005; Twohig, 2009a; Woidneck et al., 
2013). Moreover, this is the first known study to examine the effectiveness of an ACT 
group for veterans who have completed a first line treatment for PTSD (CPT, PE, 
EMDR), yet continue to experience PTSD/subthreshold PTSD. Results found ACT to be 
an effective intervention for improving PTSD symptoms and increasing valued living in 
veterans with refractory PTSD. Despite these gains, we reported that a majority of 
veterans in our study remained above the clinical cutoff for meaningful change. These 
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findings are consistent with previous research suggesting that nearly one-third to one-half 
of veterans who receive exposure-based therapies do not respond to treatment at the level 
that is expected (Schottenbauer et al., 2008; Steenkamp et al., 2015). Overall, this study 
provides evidence for ACT as an intervention for PTSD, however, the long-term 
effectiveness appears limited or in need of further attention.  
Despite the existing data for effective PTSD treatments, research shows that 
treatment gains are not always maintained at follow-up. For example, a recent study 
offered an extensive and critical review regarding the efficacy of first-line 
psychotherapies for veterans and military personal with PTSD. Results showed that CPT 
and PE outperformed treatment-as-usual and waitlist controls, however, only 49-70% of 
individuals showed a clinically meaningful change (10- to 12-point change on PTSD 
symptoms). Furthermore, results showed that PTSD scores at posttreatment remained at 
or above the clinical cutoff for PTSD and nearly two-thirds of the military 
personal/veterans retained their PTSD diagnosis posttreatment (Steenkamp et al., 2015). 
Therefore, our study results at follow-up are within the existing ranges presented in the 
literature and may be expected. Furthermore, findings from this study further illuminate 
the need for continued resources and therapeutic options for veterans following the 
completion of a trauma-focused therapy. 
One such option is to provide veterans the opportunity to attend a non-trauma 
focused psychotherapy group. Evidence indicates that group psychotherapy provides 
social support, while providing an opportunity to practice exposure to social contexts 
(Ready et al., 2012; Sripada et al., 2016). Therefore, attending group therapy may directly 
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target experiential avoidance and provide corrective learning experiences for veterans 
with PTSD. From an ACT perspective, PTSD is often maintained by behavioral 
avoidance or experiential avoidance (Thompson & Waltz, 2010). Thus, offering a group 
that emphasizes acceptance may be more effective than a group than emphasizes fear 
reduction.  
 This study contributes to the ongoing debate on whether tolerance or fear 
reduction is a more effective model for the treatment of PTSD (Bluett, Zoellner & Feeny, 
2013). Research suggests that promoting tolerance in the presence of fear or distress 
creates more robust learning (inhibitory learning; Craske et al., 2008). Moreover, the 
ACT treatment model aims to move beyond tolerance to acceptance to further increase 
inhibitory learning (Thompson et al., 2013). The ACT treatment model promotes 
exposure as a way to practice acceptance in the presence of distress- with the purpose of 
living a more meaningful life (Eifert & Forsyth, 2005). Overall, findings from this study 
suggest that a mindfulness and acceptance-based intervention increases ones’ progress 
towards valued living. Additionally, anecdotal evidence regarding the success of weekly 
behavioral commitments, suggests that veterans were utilizing acceptance strategies in 
previously avoided contexts, in order to move towards personal values.  
There is a growing body of research aiming to understand, define and treat moral 
injury. For example, a recent study interviewed fourteen male veterans/military personal 
in efforts to clarify the contextual factors that may lead to or be perceived as a moral 
injury event (MIE). Similar to our study sample- all fourteen participants had received 
outpatient treatment for PTSD, failed to improve, and were completing intensive 
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residential treatment for PTSD. Interestingly, the veterans and military personal reported 
psychological experiences or internal experiences as being a greater factor in determining 
moral injury compared to organizational, cultural, and environmental experiences 
(Currier, McCormick, et al., 2015). Our study compliments these findings, by providing 
quantitative data regarding the number of moral injury events and type of MIEs 
experienced by veterans with PTSD.  
Recently, attention has been directed to understanding the interplay between 
posttraumatic stress and moral injury. The role of shame was examined in this study, as it 
appears to be a maintaining factor for both moral injury (A Nieuwsma et al., 2015) and 
PTSD (A Nieuwsma et al., 2015; Currier, Holland, & Malott, 2015; Currier, McCormick, 
et al., 2015; Gutierrez & Hagedorn, 2013). As shown in the results, shame did not 
improve over the course of treatment. These findings are inconsistent with a large clinical 
trial, which found ACT to be an effective intervention for shame (J. B. Luoma, 
Kohlenberg, Hayes, & Fletcher, 2012). Moreover, research has shown that interventions 
that target shame directly tend to be more effective (J. B. Luoma et al., 2008). One 
possible conclusion is that our intervention did not appropriately target the construct of 
shame. In conclusion, further research is needed to understand the construct of moral 
injury, the relationship to posttraumatic stress, and how underlying factors such as shame 
may inhibit long-term recovery.  
 
Clinical Implications 
 
 
This study offers promising implications for the treatment of PTSD among 
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veterans with chronic PTSD. First, this study provides some indication that an ACT 
protocol for PTSD can be effective with veterans in a group setting. Second, results 
showed significant improvements towards valued living, which provides early 
implications that a values-driven protocol is useful for veterans with PTSD. Third, data 
from this study contributes to the growing body of literature testing alternative and 
complimentary treatments for PTSD. Furthermore, this study supports previous research 
indicating that ACT is an effective treatment for depression and improves general 
wellbeing. 
As previously mentioned, high dropout rates and poor response to treatment is not 
uncommon among PTSD treatments. Many veterans who complete a first-line treatment 
for PTSD will continue to experience symptoms and dysfunction posttreatment. Of 
surprise, many researchers do not report the need for continued care among treatment 
completers (Steenkamp et al., 2015). Veterans recruited for this study were quite 
obviously in need of treatment above and beyond the prescribed dosage of 10-12 sessions 
offered in a trauma-focused treatment protocol. Furthermore, ongoing referrals to the 
group, suggest that treatment providers acknowledge that completion of an EBT for 
PTSD may not be sufficient for some veterans. In sum, findings from this study would 
encourage the Veteran’s Health Care Administration along with mental health providers 
to continue to provide and improve upon continued care options, such as group therapy, 
for veterans with refractory PTSD.  
Extensive research has found group therapy to have strong efficacy, retention, and 
patient acceptability in the treatment of PTSD (e.g., Barrera et al., 2013; Sloan et al., 
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2013). Consistent with existing literature, veterans in this study found the eight-week 
ACT group to be highly acceptable. It is likely that veterans who have completed a 
trauma-focused intervention continue to need guidance in clarifying their values after 
trauma as well as learning new strategies to manage residual symptoms. ACT is a natural 
fit for chronic PTSD. Taken together, an ACT group may be an excellent next-step 
treatment option for veterans who have completed a trauma-focused intervention.  
 Lastly, this study informs both researchers and clinicians about the pervasive and 
potent impact of moral injury events. Findings from this study suggest that a number of 
veterans with PTSD report moral injury events. Further, nonsignificant findings suggest 
that moral injury may be a difficult construct to shift. Of interest, a recent conceptual 
paper by Nieuwsma et al. (2015) suggested that ACT might be applicable in both 
conceptualizing and treating moral injury. In brief, the article suggests that “ACT works 
with those who have suffered moral injury by assisting them to explore and open up to 
the emotional and thought aspects of their injuries, seeing what values were violated, and 
reengaging in meaningful ways” (A Nieuwsma et al., 2015). Finally, this study provides 
some indication that clinicians should consider moral injury when treating PTSD. While, 
no evidence-based treatments exist for moral injury, there has been one preliminary 
attempt to develop an appropriate treatment. This study highlights the need for an 
intervention that targets moral injury and associated symptoms such as guilt and shame. 
 
Mixed Findings  
 
While results showed significant improvements on PTSD symptoms, depression 
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symptoms, and overall wellbeing from pretreatment to post treatment, these gains were 
not maintained at follow-up. This might suggest that while an ACT group for refractory 
PTSD may lead to positive treatment gains during active treatment, it does not result in 
robust changes following treatment termination. On the contrary, veteran’s progress 
towards valued living appeared to improve over the course of treatment and maintain 
after treatment was terminated. Thus, an 8-week ACT intervention may be effective at 
motivating veterans to make behavioral changes that are aligned with their long-term 
goals. On the contrary, the length and depth of the intervention may have been 
insufficient at targeting the psychological difficulties faced by the veterans in the group.  
As shown in the results, contrary to predictions, there were many measures that 
did not change over the course of treatment and appeared to worsen from pretreatment to 
follow-up. Specifically, a measure of quality of life improved pretreatment but decreased 
from pretreatment to follow-up, while a measure of shame did not significantly change 
over the course of treatment. Additionally, the primary process of change measure, 
psychological flexibility, did not significantly change over the course of treatment and 
cognitive defusion appeared to improve on somatic concerns and emotion regulation 
during treatment, but did not maintain at follow-up. A similar conclusion may be drawn, 
while an ACT group may be helpful in some arenas for veterans during treatment, an 
eight-week intervention may not be an appropriate match for the chronicity of the 
veterans’ PTSD and associated symptoms.  
The results raise several questions regarding the long-term effectiveness of an 
ACT group intervention for veterans with refractory PTSD. Findings from this study 
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suggest that veterans benefit in some capacity by attending an experiential, acceptance-
based intervention following prolonged exposure therapy or cognitive processing therapy. 
However, the decline of treatment gains posttreatment suggests that additional, optional 
treatments should be made available for veterans with chronic PTSD including booster 
sessions, ongoing groups, and monthly support groups that emphasize behavior change 
and valued living. It is also important to consider that providing a theoretically distinct 
model for treating PTSD might lead to confusion for a veteran who has completed 
cognitive processing therapy. Specifically, a veteran may struggle to integrate the 
concepts of acceptance and defusion, as they may appear counterintuitive for a veteran 
who had previously relied on principles of cognitive restructuring for recovery. In sum, 
results from this study highlight the potential of secondary treatment options for veterans 
with refractory PTSD; however, the duration, frequency, forum, and method of these 
treatments remain an empirical question.  
 
Limitations and Future Directions 
 
 While findings from this study are encouraging, it is not without limitations. First, 
the study lacked a control group, thus we were unable to compare the efficacy of this 
intervention to other treatment groups provided to veterans with PTSD. Because this 
study was exploratory no control group was selected, however a wait-list or control group 
could be implemented as a next step comparison condition. Second, retention was poor at 
both posttreatment and follow-up. However, dropout rates from this study were 
comparable to previous studies and the Veterans Health Administration acknowledges 
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that treatment retention and dropout remains an issue with veterans with PTSD (Seal et 
al., 2010). Third, imputed data was estimated using data from only twelve veterans who 
completed follow-up. It is hard to know if these twelve individuals accurately represented 
the progress of the entire sample. Taken together, future research should aim to recruit a 
large number of veterans given the prevalence of treatment dropout. It is also possible 
that providing an online follow-up versus paper-pencil would reduce participant burden 
and increase follow-up participation. 
 Fourth, the study included veterans who met criteria for either PTSD or 
subthreshold PTSD. This may be an issue when trying to generalize findings to other 
second-line treatments for PTSD. On the contrary, research has shown that a major 
limitation in trauma research is the emphasis on the diagnostic category of PTSD, which 
does not accurately account for individuals with marked impairment who do not meet 
diagnostic criteria (Bryant et al., 2015). Thus, our study sample may be a more accurate 
clinical representation of veterans with long-standing PTSD. Notably, the study sample 
included veterans from a variety of eras, branches, and rank. The heterogeneity of the 
sample may have adversely impacted treatment. For example, one’s chronicity of PTSD, 
along with the age gap between some of the group members may have impacted a 
veteran’s ability to engage and participate in treatment.  
Furthermore, exploring ACT as a treatment for moral injury was one aim of this 
study. However, upon piloting a standalone moral injury group—study clinicians 
recognized the difficulty in directly targeting a construct that has multiple definitions and 
very few validated measures. Therefore, future researchers should first aim to define 
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moral injury and understand the boundaries of the construct before creating an 
intervention. Furthermore, the MIES, was effective at quantifying the number of moral 
injury events, but did not provide information regarding the psychological impact of 
MIEs. Fortunately, a new assessment on moral injury for military personal has recently 
been developed, Future researchers should utilize the moral injury-questionnaire military 
(MIQ-M) in hopes of providing insight into the psychological impact of moral injury 
within veterans (Currier, Holland, Drescher, & Foy, 2015).  
Lastly, future research and clinical trials need to be implemented in order to 
further assess the effectiveness of ACT for PTSD. Larger clinical trials examining ACT 
for PTSD have been conducted, however, the data has yet to be published. The 
publication of previous research will help future researchers refine and adapt existing 
protocols and research methods. Additionally, stepped-models of care for veterans with 
PTSD should be explored. Specifically, researchers should examine the longitudinal 
effects of providing a second line treatment group following completion of a first line 
treatment for PTSD. It is possible that effective treatment for PTSD requires multiple 
steps in order to create long-term change.  
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Recruitment Letter 
Hi All, 
 
We will be starting an Acceptance and Commitment Therapy (ACT) group for PTSD & 
Moral Injury. In the effort to provide more options for recovery/posttraumatic growth, 
this group will be restricted to those Veterans who are diagnosed with PTSD or 
subclinical PTSD resulting from combat or MST. Veterans must be group appropriate 
without an axis II diagnosis. This will be a closed group that will last between 
approximately 8 sessions and meets on Tuesdays from 2:00pm to 4:00 for 120 minutes 
starting on (date). Please also refer to the attached flyer. All Vets need to be referred to 
either myself via phone, email, or CPRS. 
  
ACT is part of the third‐wave behavioral therapy and can help veterans gain more 
psychological flexibility, increase willingness to experience their internal experiences 
(i.e., thoughts, emotions, sensations), explore values, and live more consistently with 
their values. ACT uses mindfulness and acceptance strategies to accomplish these goals, 
therefore, veterans will be led through mindfulness exercises and taught how to 
increase their willingness to experience unwanted events, emotions, and thoughts. This 
class is for Veterans who are searching for a more meaningful/purpose driven life and 
want to learn when and how to apply both aspects of change and acceptance. 
  
When: Tuesdays 2:00pm to 6:30pm 
  
Where: Otter Creek, Bldg 16 
  
Start date: XXX 
  
For more information and/or to refer a veteran please contact either: Brandon Yabko, 
Ph.D. (ext. 2870) or Ellen Bluett  
99 
 
Appendix B 
Measures
100 
 
Item No. 
SESSION #___________    ID #: __________ 
 
 
INTERNALIZED SHAME SCALE
1 I felt like I am never quite good enough. 
2 I felt somehow left out. 
3 I thought that people looked down on me. 
4 I scolded myself and put myself down. 
5 I felt insecure about others’ opinions of me. 
6 Compared to other people, I felt like I somehow never measure up. 
7 I saw myself as being very small and insignificant. 
8 I felt intensely inadequate and full of self-doubt. 
9 I felt as if I am somehow defective as a person, like there is something basically 
wrong with me. 
10 I compared myself to others and felt I am just not as important. 
11 I had an overpowering dread that my faults will be revealed in front of others. 
12 I saw myself striving for perfection only to continually fall short. 
13 I thought that others are able to see my defects. 
14 I felt like I could beat myself over the head with a club when I made a mistake. 
15 I wanted to shrink away when I made a mistake. 
16 I replayed painful events over and over in my mind until I was overwhelmed. 
17 At times I felt like I would break into a thousand pieces. 
18 I felt as if I had lost control over my body functions and my feelings. 
19 Sometimes I felt no bigger than a pea. 
20 At times I felt so exposed that I wished the earth would open up and swallow me. 
21 I had this painful gap within me that I was not able to fill. 
22 I felt empty and unfulfilled. 
23 My loneliness was more like emptiness. 
24 I felt like there is something missing. 
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PCL-5 
 
 
SESSION:____________      ID #: __________ 
 
Keeping this worst event in mind, read each of the problems below and then 
circle one of the numbers to the right to indicate how much you have been 
bothered by that problem in the past month. 
 
 
 Not at 
all 
A little 
bit 
 
Moderate 
Quite 
a bit 
 
Extreme 
Repeated, disturbing, and unwanted memories 
of the stressful experience? 
0 1 2 3 4 
Repeated, disturbing dreams of the stressful 
experience? 
0 1 2 3 4 
Suddenly feeling or acting as if the stressful 
experience were actually happening again (as 
if you were actually back there reliving it)? 
0 1 2 3 4 
Feeling very upset when something reminded 
you of the stressful experience? 
0 1 2 3 4 
Having strong physical reactions when 
something reminded you of the stressful 
experience (for example, heart pounding, 
trouble breathing, sweating)? 
0 1 2 3 4 
Avoiding memories, thoughts, or feelings 
related to the stressful experience? 
0 1 2 3 4 
Avoiding external reminders of the stressful 
experience (for example, people, places, 
conversations, activities, objects, or 
situations)? 
0 1 2 3 4 
Trouble remembering important parts of the 
stressful experience? 
0 1 2 3 4 
Having strong negative beliefs about yourself, 
other people, or the world (for example, 
having thoughts such as: I am bad, there is 
something seriously wrong with me, no one 
can be trusted, the world is completely 
dangerous)? 
0 1 2 3 4 
Blaming yourself or someone else for the 
stressful experience or what happened after 
it? 
0 1 2 3 4 
Having strong negative feelings such as fear, 
horror, anger, guilt, or shame? 
0 1 2 3 4 
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 Not at 
all 
A little 
bit 
 
Moderate 
Quite 
a bit 
 
Extreme 
Loss of interest in activities you used to enjoy? 0 1 2 3 4 
Feeling distant or cut off from other people? 
 
0 1 2 3 4 
Trouble experiencing positive feelings (for 
example, being unable to feel happiness or 
have loving feelings for people close to you)? 
0 1 2 3 4 
Irritable behavior, angry outbursts, or acting 
aggressively? 
0 1 2 3 4 
Taking too many risks or doing things that 
could cause you harm? 
0 1 2 3 4 
Being “superalert” or watchful or on guard? 0 1 2 3 4 
Feeling jumpy or easily startled? 0 1 2 3 4 
Having difficulty concentrating? 0 1 2 3 4 
Trouble falling or staying asleep? 0 1 2 3 4 
 
  
103 
 
SESSION: __________ ID #: ____ 
 
 
 
 
WHO (Five) Well-Being Index (1998 version) 
 
Please indicate for each of the five statements which is closest to how you have been 
feeling over the last two weeks. Notice that higher numbers mean better well-being. 
 		
Over the last two weeks 
All of 
the time 
Most of the
time 
More than 
half of the 
time 
Less than 
half of the 
time 
Some of 
the time At no time
1 I have felt cheerful and in 
good spirits 
5 4 3 2 1 0 
2 I have felt calm and 
relaxed 
5 4 3 2 1 0 
3 I have felt active and 
vigorous 
5 4 3 2 1 0 
4 I woke up feeling fresh 
and rested 
5 4 3 2 1 0 
5 My daily life has been 
filled with things that 
interest me 
5 4 3 2 1 0 
 
Example: If you have felt cheerful and in good spirits more than half of the time during 
the last two weeks, put a tick in the box with the number 3 in the upper right corner. 
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PHQ-9 
SESSION:____________      ID #: __________ 
 
Over	the	last	two	weeks	how	often	have	you	been	bothered	by	any	of	the	
following	problems?	Circle	one.		
 
1.	Little	interest	or	pleasure	in	doing	things	
   0.	Not	at	all	 1.	Several	Days 2. More than half of the days	 3.	Nearly every day
 
2.	Feeling	down,	depressed	or	hopeless	
   0.	Not	at	all	 1.	Several	Days 2. More than half of the days	 3.	Nearly every day
 
3. Trouble	falling	or	staying	asleep	or	sleeping	too	much	
   0.	Not	at	all	 1.	Several	Days 2. More than half of the days	 3.	Nearly every day
 
4. Feeling	tired	or	having	little	energy	
   0.	Not	at	all	 1.	Several	Days 2. More than half of the days	 3.	Nearly every day
 
5. Poor	appetite	or	over	eating	
   0.	Not	at	all	 1.	Several	Days 2. More than half of the days	 3.	Nearly every day
 
6. Feeling	bad	about	yourself‐-‐or	that	you	are	a	failure	or	have	let	your	family	
down	
   0.	Not	at	all	 1.	Several	Days 2. More than half of the days	 3.	Nearly every day
 
7. Trouble	concentrating	on	things	such	as	reading	a	newspaper	or	watching	
television	
   0.	Not	at	all	 1.	Several	Days 2. More than half of the days	 3.	Nearly every day
 
8. Moving	or	speaking	so	slowly	that	other	people	have	noticed?	Or	the	opposite‐-‐
being	so	fidgety	or	restless	that	you	have	been	moving	around	a	lot	more	than	
usual	
   
0.	Not	at	all	 1.	Several	Days 2. More than half of the days	 3.	Nearly every day
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9. Thoughts	that	you	would	be	better	off	dead	or	hurting	yourself	in	some	way?	
   0.	Not	at	all	 1.	Several	Days 2. More than half of the days	 3.	Nearly every day
 
	
If	you	checked	off	any	problems,	how	difficult	have	these	problems	made	it	for	
you	to	do	your	work,	take	care	of	things	at	home,	or	get	along	with	other	people?	      
0.	Not	difficult	at	all	 1.	Somewhat	difficult	 2.	Very	difficult	 3.	 Extremely	
difficulty	
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SESSION #:____________      ID #: __________ 
 
VQ 
 
 
Please read each statement carefully and then circle the number which best 
describes how much the statement was for you DURING THE PAST WEEK, 
INCLUDING TODAY 
 
 
  1 2 3 4 5 6 
 Not at all true      Completely true 
 
1. I spent a lot of time thinking about the past or future, rather than being engaged in 
activities that mattered to me 
2. I was basically on “auto-pilot” most of the time 
3. I worked toward my goals even if I didn’t feel motivated to 
4. I was proud about how I lived my life  
5. I made progress in the areas of my life I care most about 
6. Difficult thoughts, feelings, or memories got in the way of what I really wanted to 
do 
7. I continued to get better at being the kind of person I want to be 
8. When things didn’t go according to plan, I gave up easily 
9. I felt like I had purpose in life 
10. It seemed like I was just “going through the motions” rather than focusing on 
what was important to me 
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SESSION:____________      ID #: __________ 
AAQ-II 
 
Below you will find a list of statements. Please rate how true each statement is for you by circling a 
number next to it. Use the scale below to make your choice.  
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Believability of Anxious Feelings and Thoughts Questionnaire (BAFT) 
 
Imagine the following thoughts occurred to you right now. How valid or 
believable would each be to you? Please use the following scale. For each 
thought, please circle a number 1 through 7 depending on how believable that 
thought is to you. 
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QUALITY OF LIFE SCALE (QOL) 
 
Please read each item and circle the number that best describes how satisfied you are at this 
time. Please answer each item even if you do not currently participate in an activity or 
have a relationship. You can be satisfied or dissatisfied with not doing the activity or 
having the relationship. 
 
  
Delighted Pleased 
Mostly 
satisfied Mixed 
Mostly 
dissatisfied Unhappy Terrible
1.  Material comforts home, food, conveniences, 
financial security  
7 6 5 4 3 2 1 
2.  Health - being physically fit and vigorous 7 6 5 4 3 2 1 
3.  Relationships with parents, siblings & other 
relatives- communicating, visiting, helping 
7 6 5 4 3 2 1 
4.  Having and rearing children  7 6 5 4 3 2 1 
5.  Close relationships with spouse or significant 
other 
7 6 5 4 3 2 1 
6.  Close friends  7 6 5 4 3 2 1 
7.  Helping and encouraging others, volunteering, 
giving advice 
7 6 5 4 3 2 1 
8.  Participating in organizations and 
public affairs  
7 6 5 4 3 2 1 
9.  Learning- attending school, improving 
understanding, getting additional knowledge  
7 6 5 4 3 2 1 
10.  Understanding yourself - knowing your assets
and limitations - knowing what life is about  
7 6 5 4 3 2 1 
11.  Work - job or in home  7 6 5 4 3 2 1 
12.  Expressing yourself creatively 7 6 5 4 3 2 1 
13.  Socializing - meeting other people, 
doing things, parties, etc.  
7 6 5 4 3 2 1 
14.  Reading, listening to music, or observing 
entertainment  
7 6 5 4 3 2 1 
15.  Participating in active recreation  7 6 5 4 3 2 1 
16.  Independence, doing for yourself  7 6 5 4 3 2 1 
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Demographics 
 
 
Name:________________________ Last 4:_______ Today’s date:__________ 
 
SOCIAL HISTORY 
 
Current marital status: 
Married Partnered Separated Divorced Never married 
Widow(er)ed 
 
Number of previous marriages, if applicable:_____ 
 
Number of children: 
____ Biological children ____ Step children ____ Adopted children 
 
Housing: 
In the past 2 months, have you been living in stable housing that you 
own, rent, or stay in as part of a household? 
No Yes 
 
Are you worried that in the next 2 months you may NOT have stable 
housing that you own, rent, or stay in as part of a household? 
No Yes. Where have you lived for most of the past 2 months? 
Apartment/House/Room – no government 
subsidy 
Apartment/House/Room – with government 
subsidy 
With friend/family 
Motel/Hotel 
Short- term institution like hospital, rehab/drug 
treatment center 
Homeless shelter 
Anywhere outside, e.g. street, vehicle, 
abandoned building 
Other 
 
Would you like to be referred to talk more about 
your housing situation? 
No Yes 
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EDUCATION 
 
What is the highest level of education you completed?  
Level completed: Year completed: 
Grade school 
GED 
High school diploma 
Professional certificate 
College without degree 
Bachelors degree 
Masters/Doctoral degree 
 
What was your GPA in high school? 
3-4 (As and Bs) 2-3 (Bs and Cs) 1-2 (Cs and Ds) 0-1 (Ds and Fs) 
 
Please check if you received the following disciplinary actions in 
high school: 
Suspended Expelled
 Not applicable If 
you were suspended or expelled, what was 
the 
reason?___________________________ 
 
Have you ever been: (check all that apply) 
Diagnosed with ADHD or ADD Diagnosed with a Learning Disorder 
Sent to an alternative school Not applicable 
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MILITARY HISTORY 
 
Branch of service: Dates of service: 
Air Force 
Air Force National Guard 
Air Force Reserve 
Army 
Army Reserve 
Army National Guard 
Marines 
Marine Reserve 
Navy 
Navy Reserve 
Coast Guard 
 
Basic Training location:__________________________ 
Date:_______________________ 
 
Advanced Training location:______________________ 
Date:_______________________ 
 
MOS/Rating/AFSC:_____________
 Pri
mary duty in military:_________________ 
 
Duty stations and dates: 
____________________________________________________________ 
____________________________________________________________ 
 
Combat tour(s): Dates of tours (Month/Year): 
Operation Enduring Freedom 
Operation Iraqi Freedom 
Desert Storm 
Korean War 
Vietnam War 
World War II 
Other:________________ 
 
Combat unit(s), if applicable:_________________________________________ 
Final rank:____ Highest rank: _____ 
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Disciplinary actions in the military: 
None Court martial 
Nonjudicial punishment (Article 15, NJP, Captain’s/Admiral’s mast, Office 
hours) 
 
 
Type of discharge:  
Honorable
Dishonorable 
General
Bad Conduct 
Other than honorable 
Entry level separation 
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WORK HISTORY 
 
Current job, if applicable:_____________________ Length of 
time at job:______ 
 
Number of jobs held since active duty: _____ Longest time at 
any one job:________ 
 
Type of jobs 
held:_______________________________________________________
__ 
 
Have you ever experienced these work problems? 
Fired or terminated from a job 
Written up at work 
Problems with supervisors or co-workers 
Not applicable 
 
LEGAL HISTORY 
 
Please check if the following apply to you: 
 
 
 
 
 Charged with crime   
Convicted of crime   
Other legal problems: _____________   
 
Are you facing current legal charges or other legal concerns? 
No Yes. Please 
describe:________________________________________ 
 
If you have experienced past legal issues, please describe: 
Charges/Convictions     Dates 
 
_____________________________________________________ 
_____________________________________________________ 
_____________________________________________________ 
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 Pre-military During military Post-military 
Gambling   
Spending money   
Overworking   
Eating   
Sexual activity   
Pornography   
Driving recklessly   
Thrill-seeking   
Other dangerous activities   
SUBSTANCE HISTORY    
HEALTH 
 
What health problems (hospitalization, significant illness/injury) did you 
have: 
 
Prior to the military? 
 
 
 
 
During the military? 
 
 
 
 
After the military? 
 
Please list current medication(s): Reason(s) taken: 
On average, how many hours of actual sleep do you get per night?_____ 
Overall, how is the quality of your sleep? 
Very poor Poor Fair Good Very good Excellent 
 
Do you have sleep apnea? 
No Don’t know Yes. When did it start? __________ 
 
 
Are you currently applying for an increase in service connection? 
No Yes 
 
Are you currently involved in an appeal of a service connection claim? 
No Yes 
 
Do you excessively engage in or have trouble controlling any of the following 
behaviors? (check all that apply) 
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Have you ever smoked or used tobacco in any form? 
No. SKIP next three questions. Yes 
 
Are you currently using tobacco products? 
No Yes. Amount: ______________. Are you interested in quitting? No 
Yes 
 
Have you tried to quit smoking or using tobacco products during the past 
year? 
No Yes. If yes, did you stop smoking? 
Yes. Date:_____________ 
No 
 
Have you quit smoking or using tobacco products more than one year ago? 
No Yes. Month:________ Year:___________ 
 
In the past year: 
 
How often did you have a drink containing alcohol? 
Never Monthly or less 2-4 times a month 2-3 times a 
week 
4-5 times a week 6+ days a week 
 
How many drinks containing alcohol did you have on a typical day when 
you were drinking? 
1 or 2 3 or 4 5 or 6 7 to 9 
10 or more Not applicable   
 
 
How often did you have six or more drinks on one occasion? 
 
Never Less than monthly Monthly Weekly
 Daily or almost daily 
 
 
Have you enrolled in a substance abuse treatment program at the VA or in 
a local community? 
No Yes. 
Date(s):____________. Type(s) of 
treatment:____________________ 
 
 
 
118
Please check if you have used any of the following substances: 
 Pre-military During military Post-military 
Marijuana   
Synthetic cannabis (spice, K2, etc.)   
MDMA (ectasy, X, E, XTC)   
Cocaine   
Methamphetamine   
Heroin   
LSD/hallucinogens   
Medication, not as prescribed   
Other:_______________________   
 
MENTAL HEALTH  
 
Please check any of the following mental health concerns you’ve experienced: 
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SAFETY 
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SESSION 1 
SESSION:____________      ID #: __________ 
 
 
Please Circle YES, NO, NOT SURE if the topic was explained today:  
 
 
Was general idea of this therapy explained? 
 
YES    NO    NOT SURE  
 
Was the concept of dropping the shovel covered? 
 
YES    NO    NOT SURE  
 
 
Was the goal of therapy (VITALITY) discussed? 
 
YES    NO    NOT SURE  
 
 
Were the 3 parts of the triangle discussed (being present, willingness, doing what matters)? 
 
 
YES    NO    NOT SURE 
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SESSION:____________      ID #: __________ 
 
 
Please Circle YES, NO, NOT SURE if the topic was explained today:  
 
 
Was a mindfulness exercise introduced? 
 
YES    NO    NOT SURE  
 
Were Values discussed? 
 
YES    NO    NOT SURE  
 
 
Was a shovel metaphor introduced? 
 
YES    NO    NOT SURE 
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SESSION 3 
 
SESSION:____________      ID #: __________ 
 
 
Please Circle YES, NO, NOT SURE if the topic was explained today:  
 
 
Was a mindfulness exercise introduced? 
 
YES    NO    NOT SURE  
 
Was difficulty in controlling emotions covered? 
 
YES    NO    NOT SURE  
 
 
Was an example of controlling thoughts or emotions provided? 
 
YES    NO    NOT SURE  
 
 
Did we discuss why people try to control emotions?  
 
 
YES    NO    NOT SURE  
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SESSION 4 
 
SESSION:____________      ID #: __________ 
 
 
Please Circle YES, NO, NOT SURE if the topic was explained today:  
 
 
Was a mindfulness exercise practiced? 
 
YES    NO    NOT SURE  
 
Was an area of values discussed? 
 
YES    NO    NOT SURE  
 
 
Was willingness discussed? 
 
YES    NO    NOT SURE  
 
 
Was an exercise for willingness (finger trap) introduced?  
 
 
YES    NO    NOT SURE  
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SESSION 5 
 
SESSION:____________      ID #: __________ 
 
 
Please Circle YES, NO, NOT SURE if the topic was explained today:  
 
 
Was a mindfulness exercise practiced? 
 
YES    NO    NOT SURE  
 
Was an area of values discussed? 
 
YES    NO    NOT SURE  
 
 
Was willingness reviewed? 
 
YES    NO    NOT SURE  
 
 
Was the concept of defusing from thoughts introduced?  
 
 
YES    NO    NOT SURE  
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SESSION 6 
 
SESSION:____________      ID #: __________ 
 
 
Please Circle YES, NO, NOT SURE if the topic was explained today:  
 
 
Was a mindfulness exercise practiced? 
 
YES    NO    NOT SURE  
 
Was an area of values discussed? 
 
YES    NO    NOT SURE  
 
 
Was defusion reviewed? 
 
YES    NO    NOT SURE  
 
 
Were exercises of defusion practiced?  
 
 
YES    NO    NOT SURE  
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SESSION 7 
 
SESSION:____________      ID #: __________ 
 
 
Please Circle YES, NO, NOT SURE if the topic was explained today:  
 
 
Was a mindfulness exercise practiced? 
 
YES    NO    NOT SURE  
 
Were committed actions reviewed? 
 
YES    NO    NOT SURE  
 
 
Was self- as- context discussed (chessboard)? 
 
YES    NO    NOT SURE 
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SESSION 8 
 
SESSION:____________      ID #: __________ 
 
 
Please Circle YES, NO, NOT SURE if the topic was explained today:  
 
 
Was a mindfulness exercise practiced? 
 
YES    NO    NOT SURE  
 
Were committed actions reviewed? 
 
YES    NO    NOT SURE  
 
Was the Passengers on the Bus Exercise practiced? 
 
YES    NO    NOT SURE  
 
Was the bill of rights reviewed? 
 
YES    NO    NOT SURE 
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Demographics 
SESSION:____________      ID #: __________ 
 
 
Please answer the following questions:  
 
1. What is your gender?  1=Female  2=Male 
 
2. What is your marital status?  1=Single   4=Separated    
2=Married   5=Remarried 
3=Divorced   6=Widowed 
   7=other 
3. What is your age? ______ 
 
4. What is your ethnicity/race?  1=African American 
2=Asian American 
3=Caucasian 
4=Hispanic 
5=Native American 
6=other __________________ 
 
5. What is your current employment status? 
1=Unemployed/not working 
2=Working part-time 
3=Working full-time (more than 30 hrs/wk) 
4=On disability 
5=Full-time student 
6=Retired 
 
6. What was the last grade of school you completed? What is your highest educational 
degree? 
 1=Ph.D., M.D. (doctoral) 
2=M.A./M.S. or equivalent 
3=Some graduate school 
4=B.A./B.S. or equivalent 
5=Associates Degree 
6=Some college 
7=High school diploma or equivalent 
8=Some high school 
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7. What is your current religious identification? 
1=Catholic 
2=Church of Jesus Christ of Latter Day Saints 
3=Protestant (Christian) specify:_______ 
4=Jewish 
5=Islam 
6=Other: specify__________ 
7=None 
 
11. Have you ever sought treatment or tried other procedures before? If yes, what did you 
try? 
1= Medication What kind? ______________ 
SRI: 1=No 2= Yes 
2= Cognitive Processing Therapy 
3= Prolonged Exposure Therapy 
4= EMDR  
5= Meditation 
6= Other:________ 
 
12. Are you taking any psychotropic medications or have you been on any in the past 6 
months? If yes, please list with the date you started the most recent dosage. 
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Appendix C 
 
Figures
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Figure C1. Posttraumatic stress symptom scores. 
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Figure C2. Well-being index and quality of life inventory. 
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Figure C3. Internalized shame scale and moral injury event scale. 
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Figure C4. Acceptance and action questionnaire and values questionnaire. 
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Figure C5. Believability of anxious feelings and thoughts.
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 Salt Lake City, UT 
 Develop and implement and effectiveness treatment trial for 
posttraumatic stress and posttraumatic growth.  
 Responsibilities: Design, coordinate, and co-facilitate a weekly 
psychotherapy group for veterans using Acceptance and Commitment 
Therapy; patient recruitment; data collection; data management; 
weekly group psychotherapy; follow-up assessments; and case 
consultation.  
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 Supervisors: Michael Twohig, Ph.D. & Brandon Yabko, Ph.D. 
 
09/12 – 05/14 Clinical Research Coordinator  
 Avalon Hills Residential Treatment Center for Eating Disorders 
 Logan, UT 
 Manage ongoing data assessment and collection of individuals 
receiving treatment at Avalon Hills. 
 Responsibilities: Data management, including tracking residents’ 
admissions and discharge data; data entry; organize IRB submissions; 
analyze data using SPSS. Published two peer-reviewed manuscripts.  
 Supervisors: Michael Twohig, Ph.D. & Whitney Matson. M.B.A. 
   
09/11 – Present Graduate Research Assistant  
 Center for Clinical Research 
 Logan, UT 
 Design, administer, and analyze clinical research using Acceptance 
and Commitment Therapy for the treatment of anxiety disorders in 
adults. 
 Responsibilities: Administer psycho-diagnostic assessments; database 
management; provide psychotherapy; and recruitment. Specializing in 
specific populations including: OCD, PTSD, and Social Anxiety. Over 
the past five years, coordinate a large randomized controlled trial for 
the treatment of Obsessive-Compulsive Disorder. 
 Supervisor: Michael Twohig, Ph.D. 
   
07/09 – 05/11 Research Coordinator 
 Center for Anxiety and Traumatic Stress 
 University of Washington, Seattle, WA 
 Research Coordinator for Optimizing Treatment for PTSD  
 (2 R01 MH066347-06) 
 Coordinate an NIMH-funded double randomized, treatment preference 
trial, investigating the (1) role of choice, (2) effects of combined 
psychotherapy and pharmacological treatment for PTSD, and (3) 
presence of co-occurring major depression with posttraumatic stress 
disorder in trauma survivors.  
 Responsibilities: Managed a large-scaled clinical trial; coordinated all 
aspects of participant recruitment and tracking; data management and 
analysis (SPSS); organized IRB submissions; SCID training; and 
completed intensive Prolonged Exposure Therapy training with Dr. 
Edna Foa.  
 Supervisor: Lori A. Zoellner, Ph.D.  
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07/09 – 05/11 Research Coordinator 
 Center for Anxiety and Traumatic Stress, 
 University of Washington, Seattle, WA 
 Research Coordinator for Helping Extinction Learning in PTSD  
 (1 R34 MH087375-01) 
Coordinate an NIMH-funded study investigating the role of an 
experimental drug aimed at enhancing learning during exposure-based 
treatment for PTSD.  
Responsibilities: Managed a large-scale clinical trial; organized IRB 
submissions; coordinated all aspects of participant recruitment and 
tracking; and managed database entry and analysis. 
 Supervisor: Lori A. Zoellner, Ph.D.  
. 
08/07 – 06/08 Undergraduate Research Assistant 
 Anxiety and Health Research Lab 
 University of Vermont, Burlington VT 
Research Assistant for Anxiety Sensitivity and Unexpected Panic 
Attacks  
An NIMH-funded study investigating anxiety sensitivity, non-clinical 
panic- attack history and panic vulnerability, using a CO2 challenge 
procedure.  
Research Assistant for Smoking Based Prevention Program for Panic  
An NIMH-funded, multi-site randomized controlled trial investigating 
the role of reducing smoking behavior and increasing anxiety 
sensitivity as a means to decrease the risk for onset of panic disorder.  
Responsibilities: Coordinated participant recruitment; completed data 
collection and entry; assisted in running participants through CO2 
inhalation task; and conducted clinical phone screens and scheduling. 
 Supervisor: Michael Zvolensky, Ph.D. 
 
01/08 – 06/08 Undergraduate Research Assistant 
 Mark Bouton Research Laboratory, University of Vermont, 
Burlington, VT 
Organized and ran a study on non-monotonic learning; ran experiment 
that investigated the presence of a non-monotonic, variable or 
changing, learning curve in rat behavior according to the context and 
presence of a particular conditioned stimulus.  
Responsibilities: Prepared animals; assisted in running daily 
experiment; monitored experiment during sessions; collected and 
organized data; and scored and coded behavior in rats.  
 Supervisor: Mark Bouton, Ph.D. 
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CLINICAL EXPERIENCE 
 
06/15 – 05/16 Psychology Practicum Student  
 Posttraumatic Stress Disorder Clinical Team 
 George E. Wahlen Department of Veterans Affairs Medical 
Center 
 Salt Lake City, UT 
 Design and implement an effectiveness treatment trial for veterans 
with PTSD. Conduct psychotherapy in a group setting for veterans 
who have completed an evidenced-based practice for PTSD and 
remain symptomatic. 
 Responsibilities: Co-lead weekly group therapy sessions for 
Posttraumatic Stress Disorder utilizing Acceptance and Commitment 
Therapy; patient recruitment; and data collection and management.  
 Supervisors: Brandon Yabko, Ph.D. & Jim Asbrand, Ph.D. 
  
03/15 – 05/16  Psychology Practicum Student  
 VITAL Rotation  
 George E. Wahlen Department of Veterans Affairs Medical 
Center 
 Salt Lake City, UT 
 Conduct cognitive and academic assessment as part of a team 
supporting academic success of undergraduate student veterans of all 
eras. Primary assessment referral questions include learning disorder, 
ADHD, and memory complaints.  
 Responsibilities: Conduct psycho-diagnostic assessments; intellectual 
assessment; achievement assessment; ADHD assessment; integrated 
assessment report writing; develop recommendations for treatment and 
academic accommodations; and provide feedback and 
recommendations to student veterans and other primary referrals.  
 Supervisor: Aaron Ahern, Ph.D. 
  
03/15 – 12/16  Psychology Practicum Student  
 Center for Persons with Disabilities 
 Logan, UT  
 Participate in diverse clinical experiences on an inter-disciplinary 
team. Responsibilities: Conduct psycho-diagnostic intake interviews of 
children, adolescents, and adults; provide comprehensive evaluations 
including assessment of learning disabilities, behavior problems, 
autism spectrum disorder, social security disability; integrated report 
writing, case management, feedback sessions; and case presentation 
and discussion in interdisciplinary team consultation with speech and 
language pathologists, physicians, and nurses.  
 Supervisor: Martin Toohill, Ph.D. 
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08/14 – 05/15 Psychology Practicum Student  
 Posttraumatic Stress Disorder Rotation  
 George E. Wahlen Department of Veterans Affairs Medical 
Center 
 Salt Lake City, UT 
 Conduct weekly psycho-diagnostic assessments, individual therapy, 
and treatment planning for trauma exposed veterans.  
 Responsibilities: Conduct psycho-diagnostic assessment including the 
PCL-5, PHQ-9, and Life Events Checklist for military-related PTSD 
with veterans from Vietnam, Persian Gulf, and OEF/OIF; crisis 
intervention; organizing the open clinic weekly; individual 
psychotherapy; and individual supervision. 
 Supervisor: Jinna Lee, Ph.D. 
  
08/14 – 08/15 Graduate Clinical Assistant  
 Avalon Hills Residential Eating Disorder Facility 
 Logan, UT 
 Provide individual and group psychotherapy to adult and adolescent 
females in a residential treatment facility for eating disorders.  
 Responsibilities: Conduct ACT, DBT, Recovery Maintenance, 
Spirituality didactic groups; facilitate process and body-image groups; 
individual psychotherapy; organize and conduct experiential exercises; 
participate in weekly multi-disciplinary team meetings, attend daily 
rounds; and conduct neuropsychological assessments.  
 Supervisor: Tera Lensgrav-Benson, Ph.D. 
  
08/13 – 05/2014 Psychology Practicum Student  
 Utah State Student Health Center 
 Primary Care Clinic 
 Logan, UT 
 Conduct psycho-diagnostic assessments and provide focused, brief-
interventions in primary care setting.  
 Responsibilities: Conduct intakes, evaluations, one-time consults and 
treatment plans; provide time-limited individual therapy; consultation 
with physicians and nurses in a multi-disciplinary primary care setting; 
and group counseling in Acceptance and Commitment Therapy for 
healthy lifestyles. 
 Supervisor: Scott Deberard, Ph.D.  
  
08/12 – 06/2013 Integrative Psychology Practicum  
 Utah State Psychology Community Clinic  
 Logan, UT 
 Provide individual therapy and assessments to children, adolescents, 
adults. 
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 Responsibilities: Conduct intake interviews, evaluations, assessment 
and diagnosis with child, adolescent, and adult community population; 
provide ongoing individual psychotherapy supported by weekly 
supervision; group supervision; and didactic training.  
 Supervisors: Susan Crowley, Ph.D. & Gretchen Gimpel-Peacock, 
Ph.D. 
  
08/11 – Present Clinical Research Assistant & Therapist  
 Center for Clinical Research 
 Logan, UT 
 Conduct individual therapy and assessments as part of a large 
randomized controlled trial for the treatment of Obsessive-Compulsive 
Disorder (OCD). 
 Responsibilities: Administer psycho-diagnostic assessments including 
the  
 Y-BOCS and MINI for OCD; provide individual psychotherapy 
including Acceptance and Commitment Therapy and Exposure and 
Response Prevention for OCD; weekly supervision; and case 
consultation across sites.  
 Supervisors: Michael Twohig, Ph.D. & Jonathan Abramowitz, Ph.D. 
  
09/12 – 12/2013 Clinical Research Coordinator  
 Center for Clinical Research 
 Logan, UT 
 Design and implement a clinical research study assessing the 
mechanisms of change in exposure therapies for socially anxious 
college students.  
 Responsibilities: Develop treatment manual; provide brief exposure-
based psychotherapy; provide referrals; and manage clinical research.  
 Supervisors: Michael Twohig, Ph.D. 
 
PEER-REVIEWED PUBLICATIONS  
 
1. Bluett, E. J., Landy*, L. L., Twohig, M. P., & Arch, J. J. (2016). Does the Theoretical 
Perspective of Exposure Framing Matter? Acceptance, Fear Reduction/Cognitive 
Reappraisal, and Values-Framing of Exposure for Social Anxiety. Journal of 
Cognitive Psychotherapy, 30(2), 77-93. 
*denotes co-first authorship 
 
2. Ong, C. W., Clyde, J. W., Bluett, E. J., Levin, M. E., & Twohig, M. P. (2016).  
 Dropout rates in exposure with response prevention for obsessive-compulsive 
 disorder: What do the data really say? Journal of Anxiety Disorders, 40, 8-17.  
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3. Loerinc, A. G., Meuret, A. E., Twohig, M. P., Rosenfield, D., Bluett, E. J., & Craske, 
M. G. (2015). Response rates for CBT for anxiety disorders: Need for 
standardized criteria. Clinical Psychology Review, 42, 72-82. 
 
4.Twohig, M. P., Bluett, E. J., Cullum, J. L., Mitchell, P. R., Powers, P. S., Lensegrav-
Benson, T., & Quakenbush-Roberts, B. (2015). Effectiveness and clinical 
response rates of a residential eating disorders facility. Eating Disorders: The 
Journal of Treatment and Prevention,1-16. 
5. Arch, J. J., Twohig, M. P., Deacon, B., Landy, L. N., & Bluett, E. J. (2015). The 
credibility of exposure therapy: Does the theoretical rationale matter? Behaviour 
Research and Therapy. 72, 81-92.  
6.Twohig, M. P., Abramowitz, J. A., Bluett, E. J., Fabricant, L., Jacoby, R. J., Morrison, 
K. L., Reuman, L., & Smith, B. (2015). Exposure therapy for OCD from an 
acceptance and commitment therapy (ACT) framework. Journal of Obsessive 
Compulsive and Related Disorders, 6, 167-173. 
7. Twohig, M. P., Bluett, E. J., Torgesen, J. G., Lensegrav-Benson, T., & Quakenbush-
Roberts, B. (2015). Who seeks residential treatment? A report of patient 
characteristics, pathology, and functioning in females at a residential treatment 
facility. Eating Disorders: The Journal of Treatment & Prevention, 23(1),1-14.  
8. Bluett, E. J., Homan, K. J., Morrison, K. L., Levin, M. E., & Twohig, M. P. (2014). 
Acceptance and commitment therapy for anxiety and OCD spectrum disorders: 
An empirical review. Journal of Anxiety Disorders, 28(6), 612-624.  
 
9. Bluett, E. J., Zoellner, L. A., & Feeny, N. C. (2014). Does change in distress matter? 
Mechanisms of change in prolonged exposure for PTSD. Journal of Behavior 
Therapy and Experimental Psychiatry, 45(1), 97-104.  
 
10. Twohig, M. P, Morrison, K. L., & Bluett, E. J. (2014). Acceptance and commitment  
 therapy for obsessive compulsive disorder and obsessive compulsive spectrum  
 disorders: A review. Current Psychiatry Reviews, 10(4), 296-307.  
 
INVITED CHAPTERS 
 
11. Twohig, M. P., Bluett, E. J., Morrison, K. L., & Woidneck, M. R. (2014). Habit 
reversal.In S.G. Hofmann (Ed.). Cognitive behavioral therapy: A complete 
reference guide. (pp.203-222). Wiley-Blackwell: West Sussex UK. 
 
12. Smith, B. M., Bluett, E. J., Lee, E. B., & Twohig, M. P. (submitted). Acceptance and 
commitment therapy for OCD. In J. S. Abramowitz, D. McKay, & E. Storch 
(Eds.) Handbook of Obsessive Compulsive Disorders Across the Lifespan. 
Hoboken, NJ: Wiley. 
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MANUSCRIPTS IN SUBMISSION 
 
13. Zoellner, Lori A., Telch, Michael J., Foa, Edna, B., Farach, F. J., McLean, C. P., 
Gallop, R., Bluett, E. J., Cobb, A., Gonzalez-Lima, F. (2016). Enhancing 
extinction learning in PTSD with brief daily imaginal exposure and methylene 
blue. Manuscript submitted for publication.  
 
14. Bluett, E. J., Lee, E. B., Simone, M., Lockhart, G., Lensegrav-Bensen, T., 
Quakenbush-Roberts, B. Twohig, M. P., (revise and resubmit). The role of body 
image psychological flexibility on the treatment of eating disorders in a 
residential facility. Eating Behavior. 
 
PROFESSIONAL PRESENTATIONS  
 
Ong, C. W., Clyde, J. W., Bluett, E. J., Levin, M. E., & Twohig, M. P. (2016, 
October). Dropout rates in exposure with response prevention for obsessive-
compulsive disorder: A meta-analytic review. Poster presented at the 
50th annual convention of the Association for Behavioral and Cognitive 
Therapies, New York, NY.  
 
Lee, E. B., Bluett, E. J., Ong, C. W., Lockhart, G., Twohig, M. P., Lensegrav-Bensen, 
T., Quakenbush-Roberts, B. (June 2016). Psychological Flexibility as a Predictor 
of Quality of Life and Eating Disorder Risk in a Residential Treatment Setting. 
Presented at the 14th Annual Association for Contextual Behavioral Science 
World Conference, Seattle, WA. 
 
Richards, S. M., Deberard, M. S., Potts, S., Wanzek, J., Bluett, E. J., & Homan, K. J. 
(2015, April). Lifestyle intervention in emerging young adulthood: A brief 
acceptance-based behavioral intervention for young adults. Poster presented at 
the annual meeting of the Society of Behavioral Medicine, San Antonio, TX. 
 
Bluett, E. J., Homan, K. J., Morrison, K. L., Levin, M. E., & Twohig, M. P. (2014, 
November). Psychological flexibility and anxiety disorders: A meta-analysis. 
Paper presented at the 48th Annual Convention meeting of the Association for 
Behavioral and Cognitive Therapies, Philadelphia, PA. 
 
Bluett, E. J., Twohig, M. P., Matson, W., Lensegrav-Benson, T., & Quakenbush-
Roberts. (2014, June). Efficacy and clinical response rates of a residential eating 
disorders facility. Paper presented at the annual World Conference of the 
Association for Contextual Behavioral Science (ACBS), Minneapolis, Minnesota.  
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Abramowitz, J. S., Berry, B. M., Bluett, E. J., Fabricant, L., Jacoby, R. J., Morrison, K. 
L., & Twohig, M. P. (2013, November). Predictors of OCD symptom dimensions: 
Obsessional beliefs and experiential avoidance. Symposium presented at the 47th 
annual convention of the Association for Behavioral and Cognitive Therapies, 
Nashville, TN. 
 
Arch, J., Deacon, B., Twohig, M. P., Bluett, E., Landy, L. (2013, November). Impact of 
ACT vs CBT rationale for exposure therapy. Paper presented at the 47th Annual 
Convention meeting of the Association for Behavioral and Cognitive Therapies, 
Nashville, TN. 
 
Bluett, E. J., Landy, L. L., Twohig, M. P., Arch, J. A. (2013, November). Does exposure 
framing matter? Comparing models of exposure in a brief intervention for social 
anxiety. Paper presented at the 47th Annual Convention of the Association of 
Behavioral and Cognitive Therapies, Nashville, TN. 
  
Bluett, E. J., Landy, L. L., Twohig, M. P., Arch, J. A. (2013, September). Does exposure 
framing matter? Comparing models of exposure in a brief intervention for social 
anxiety. Symposium presented for the 1st Annual Convention of the Association 
of Contextual and Behavior Science Regional Conference, Golden, CO.  
 
Zoellner, L., Bluett, E. J., & Feeny, N. C. (2013, July). Is fear reduction necessary 
during imaginal exposure in prolonged exposure therapy for PTSD mechanisms?  
Invited Address for the 56th Division of the American Psychological Association 
Annual Convention, Honolulu, HI. 
 
Twohig, M., Abramowitz, J., Fabricant, L., Morrison, K., & Bluett, E. (2012, July). 
Combining Acceptance and Commitment Therapy with Exposure and Response 
Prevention to enhance the treatment of OCD. Poster presented at the annual 
conference of the International OCD Foundation, Chicago, IL. 
 
Bluett, E. J., Zoellner, L., & Feeny, N. C. (2010, June). Mechanisms underlying 
exposure therapy for chronic PTSD: Between-session habituation and distress 
tolerance. Poster submitted for the 6th Annual Convention of the World Congress 
of Behavioral and Cognitive Therapies, Boston, MA. 
 
Bluett, E. J., Zoellner, L. A., & Feeny, N. C. (2010, November). Homework adherence: 
A possible moderator for between-session habituation and treatment outcome in 
exposure therapy for chronic PTSD. Poster submitted for the 44th Annual 
Convention of the Association of Behavioral and Cognitive Therapies, San 
Francisco, CA. 
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Chen, J., Jun, J., Bluett, E. J., & Zoellner, L. A. (2010, November). Emotional numbing 
takes its toll on recall in individuals with PTSD. Poster submitted for the 44th 
Annual Convention of the Association of Behavioral and Cognitive Therapies, 
San Francisco, CA. 
 
PEER REVIEW 
04/2015  Journal of Contextual Behavioral Science  
12/2014  Journal of Obsessive Compulsive and Related Disorders 
10/2014   Cognitive and Behavioral Practice 
05/2014  Cognitive and Behavioral Practice 
10/2011  Behaviour Research and Therapy  
 
SUBMITTED GRANTS  
 
Title: A Test of Acceptance and Commitment Therapy for Marijuana Dependence & 
PTSD 
Date submitted: March 2012 (unfunded) 
Dates: 10/12 - 09/16 
Amount of Award: $1,166,880 (Direct Costs)  
Funding Source: VA Clinical Science Research and Development (CSR&D) 
Role: Assist with submission. 
 
TEACHING EXPERIENCE 
 
02/2015 Abnormal Psychology 
 Guest Lecturer: Eating Disorders 
 Utah State University  
 
05/2012 Psychology 1010 General Psychology  
 Guest Lecturer: Yoga and Psychology 
 Utah State University 
 
04/2012 Psychology 3050  
 Guest Lecturer: Randomized Controlled Trials  
 Utah State University  
 
Fall 2011  Graduate Teaching Assistant 
Spring 2012 PSY 1010: General Psychology, Utah State University, 
 Planned, taught, and managed lab sections; held regular office hours; 
graded 
 tests and written assignments; collaborated with professor and other 
teaching assistants; lectured in professors’ absence; provided 
additional support for students as necessary. 
 Supervisors: Scott Bates, Ph.D. & Jennifer Grewe, Ph.D. 
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PROFESSIONAL DEVELOPMENT TRAINING 
May 2016  From Cancer to Health 
 Presenter: Barbara Andersen, Ph.D 
 Columbus, Ohio 
 
June 2014  Relational Frame Theory in Clinical Practice 
 Presenters: M. Villatte, Ph.D.; Sonja Batten, Ph.D. 
 Minneapolis, MN 
 
February 2014  Acceptance and Commitment Therapy Bootcamp 
 Presenters: Steven Hayes, Ph.D.; Kelly Wilson, Ph.D.; Kirk Stroshal, 
Ph.D. 
 Reno, NV 
 
September 2013  Veterans Yoga Project  
 Presenter: Daniel Libby Ph.D. 
 Feathered Pipe Foundation, Helena, MT 
 
February 2013 Cultural Competence Training  
 Presenter: Michael P Twohig, Ph.D., Melanie Domenech-Rodriguez, 
Ph.D. 
 Utah State University, Logan, UT 
 
September 2012 Acceptance and Commitment Therapy Experiential Workshop 
 Presenter: Michael P Twohig, Ph.D.  
 Utah State University, Logan, UT  
 
October 2013 “Mindfulness & DBT” 
 Presenter: Marsha Linehan, Ph.D. 
 FACES conferences, Seattle, WA 
 
October 2013 “The Art & Science of Mindfulness: Integrating Mindfulness into 
Psychotherapy” 
 Presenter: Shauna Shapiro, Ph.D. 
 FACES conferences, Seattle, WA 
 
October 2013 “Mindfulness & Self Compassion” 
 Presenter: Kristin Neff, Ph.D. 
 FACES conferences, Seattle, WA 
 
July 2012 “The Compassionate Use of Exposure Strategies in ACT” 
 Presenter: John Forsyth, Ph.D. 
 Association for Contextual Behavioral Science World Conference, 
Baltimore, MD 
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October 2010 Prolonged Exposure for the Treatment of PTSD (3-day training) 
 Presenter: Edna D. Foa, Ph.D. 
 Case Western Reserve University, Cleveland, OH  
 
HONORS AND AWARDS 
 
2015  Dissertation Fellowship Award ($5,000), Utah State University,  
 School of Graduate Studies  
 
2013  Walter Borg Research Scholarship ($3,200), Utah State University, 
Department of Psychology 
 
2011 – 2014 Krantz Research Award ($420), Utah State University, Department of 
Psychology 
 
2011 – 2014 Graduate Student Senate Travel Award ($300), Utah State University 
 
2004 – 2008   Presidential Scholarship University of Vermont 
 
PROFESSIONAL ASSOCIATIONS  
Association for Contextual Behavioral Science (ACBS), Student Member 
Association for Behavioral and Cognitive Therapies (ABCT), Student Member 
American Psychological Association (APA) – Division 12, Student Member  
Society for Behavioral Medicine (SBM), Student Member 
 
